NEK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A6NMY6 | S134 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKAsMKGLGtDEDsLIEIICsRtNQELQEINRVyKEMYKtD |
| A6NMY6 | T123 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| A6NMY6 | T136 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | AsMKGLGtDEDsLIEIICsRtNQELQEINRVyKEMYKtDLE |
| A6NMY6 | T163 | Sugiyama | ANXA2P2 ANX2L2 ANX2P2 LPC2B | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| O00161 | S23 | Sugiyama | SNAP23 | NLssEEIQQRAHQITDEsLEstRRILGLAIEsQDAGIKtIt |
| O00273 | S302 | Sugiyama | DFFA DFF1 DFF45 H13 | TETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDLQN |
| O00273 | T300 | Sugiyama | DFFA DFF1 DFF45 H13 | KKTETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDL |
| O14777 | S165 | EPSD|PSP | NDC80 HEC HEC1 KNTC2 | TKFEEEVPRIFKDLGYPFALsKSSMYTVGAPHTWPHIVAAL |
| O14908 | T238 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | FDMISQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPs |
| O14908 | T242 | Sugiyama | GIPC1 C19orf3 GIPC RGS19IP1 | SQRsAGGRPGsGPQLGtGRGtLRLRsRGPAtVEDLPsAFEE |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15127 | T109 | Sugiyama | SCAMP2 | QEELDRKAAELERKERELQNtVANLHVRQNNWPPLPSWCPV |
| O15212 | S53 | Sugiyama | PFDN6 HKE2 PFD6 | LEAQLtENNIVKEELALLDGsNVVFKLLGPVLVKQELGEAR |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15347 | S14 | Sugiyama | HMGB3 HMG2A HMG4 | _______MAKGDPKKPKGKMsAYAFFVQtCREEHKKKNPEV |
| O15347 | T22 | Sugiyama | HMGB3 HMG2A HMG4 | AKGDPKKPKGKMsAYAFFVQtCREEHKKKNPEVPVNFAEFS |
| O15446 | S64 | Sugiyama | POLR1G ASE1 CAST CD3EAP PAF49 | LIQAPADFAPECFNGRHVPLsGsQIVKGKLAGKRHRyRVLS |
| O43175 | T78 | Sugiyama | PHGDH PGDH3 | KVTADVINAAEKLQVVGRAGtGVDNVDLEAAtRKGILVMNT |
| O43175 | T89 | Sugiyama | PHGDH PGDH3 | KLQVVGRAGtGVDNVDLEAAtRKGILVMNTPNGNSLSAAEL |
| O43390 | T134 | Sugiyama | HNRNPR HNRPR | KVQESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43399 | S84 | Sugiyama | TPD52L2 | RQVLAAKERHCGELKRRLGLstLGELKQNLsRsWHDVQVss |
| O43399 | T85 | Sugiyama | TPD52L2 | QVLAAKERHCGELKRRLGLstLGELKQNLsRsWHDVQVssA |
| O43707 | T359 | Sugiyama | ACTN4 | RRVHKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKM |
| O43707 | T362 | Sugiyama | ACTN4 | HKPPKVQEKCQLEINFNtLQtKLRLSNRPAFMPSEGKMVSD |
| O43707 | T613 | Sugiyama | ACTN4 | EAQRIAESNHIKLsGsNPyttVtPQIINsKWEKVQQLVPKR |
| O43852 | T196 | Sugiyama | CALU | FtAFLHPEEyDyMKDIVVQEtMEDIDKNADGFIDLEEyIGD |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60220 | S94 | Sugiyama | TIMM8A DDP DDP1 TIM8A | SQFILNRLEQTQKSKPVFSEsLsD_________________ |
| O60271 | T191 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | MEHLERTKLHQLsGsDQLEstAHsRIRKERPIsLGIFPLPA |
| O60271 | T418 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | DEGADLLGMGREVENLILENtQLLEtKNALNIVKNDLIAKV |
| O60271 | T423 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | LLGMGREVENLILENtQLLEtKNALNIVKNDLIAKVDELTC |
| O60361 | T88 | Sugiyama | NME2P1 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| O60506 | T131 | Sugiyama | SYNCRIP HNRPQ NSAP1 | KVADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60814 | S39 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | T289 | Sugiyama | EIF5B IF2 KIAA0741 | QKESQRKFEEETVKSKVTVDtGVIPAsEEKAEtPtAAEDDN |
| O75116 | T573 | Sugiyama | ROCK2 KIAA0619 | STEKVNQLQRQLDEtNALLRtESDTAARLRKTQAESSKQIQ |
| O75534 | T761 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | GPKAVAAPRPDRLVNRLKNItLDDAsAPRLMVLRQPRGPDN |
| O95071 | T119 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | GRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsGVGGs |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00491 | T177 | Sugiyama | PNP NP | DRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVAG |
| P00505 | T192 | Sugiyama | GOT2 KYAT4 | AGMQLQGyRYYDPKtCGFDFtGAVEDISKIPEQSVLLLHAC |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04040 | S515 | Sugiyama | CAT | ALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | T119 | Sugiyama | ALDOA ALDA | KsKGGVVGIKVDKGVVPLAGtNGEtttQGLDGLsERCAQYK |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04083 | T169 | Sugiyama | ANXA1 ANX1 LPC1 | IRDINRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRs |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04406 | S151 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | FVMGVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIV |
| P04406 | S312 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | sstFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMA |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T154 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GVNHEKYDNSLKIIsNAsCttNCLAPLAKVIHDNFGIVEGL |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04632 | T143 | Sugiyama | CAPNS1 CAPN4 CAPNS | ILNKVVTRHPDLKTDGFGIDtCRSMVAVMDSDTTGKLGFEE |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T174 | Sugiyama | HSPB1 HSP27 HSP28 | SSsLsPEGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGP |
| P04792 | T180 | Sugiyama | HSPB1 HSP27 HSP28 | EGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsD |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05187 | T185 | Sugiyama | ALPP PLAP | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADVPASARQEGC |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05455 | T302 | Sugiyama | SSB | ALGKAKDANNGNLQLRNKEVtWEVLEGEVEKEALKKIIEDQ |
| P06703 | S46 | Sugiyama | S100A6 CACY | KHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRNKDQ |
| P06703 | T43 | Sugiyama | S100A6 CACY | EGDKHTLSKKELKELIQKELtIGsKLQDAEIARLMEDLDRN |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | S272 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | FRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsI |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | S40 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGK |
| P06733 | S419 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | CRSERLAKyNQLLRIEEELGsKAKFAGRNFRNPLAK_____ |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T229 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DEGGFAPNILENKEGLELLKtAIGKAGYTDKVVIGMDVAAS |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06733 | T41 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKG |
| P06733 | T55 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | VPsGAstGIyEALELRDNDKtRYMGKGVSKAVEHINKtIAP |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y407 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GLCtGQIKTGAPCRSERLAKyNQLLRIEEELGsKAKFAGRN |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P06748 | S260 | Sugiyama | NPM1 NPM | GPssVEDIKAKMQAsIEKGGsLPKVEAKFINyVKNCFRMtD |
| P06748 | T279 | Sugiyama | NPM1 NPM | GsLPKVEAKFINyVKNCFRMtDQEAIQDLWQWRKsL_____ |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S44 | Sugiyama | LDHB | ITVVGVGQVGMACAISILGKsLADELALVDVLEDKLKGEMM |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | T428 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | DKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFPA |
| P07355 | S134 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKAsMKGLGtDEDsLIEIICsRtNQELQEINRVyKEMYKtD |
| P07355 | T123 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | LKtPAQyDAsELKAsMKGLGtDEDsLIEIICsRtNQELQEI |
| P07355 | T136 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | AsMKGLGtDEDsLIEIICsRtNQELQEINRVyKEMYKtDLE |
| P07355 | T163 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | INRVyKEMYKtDLEKDIIsDtsGDFRKLMVALAKGRRAEDG |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T312 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | QVFDAKNMMAACDPRHGRyLtVAAVFRGRMsMKEVDEQMLN |
| P07437 | T55 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEPGtMDs |
| P07437 | Y310 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tQQVFDAKNMMAACDPRHGRyLtVAAVFRGRMsMKEVDEQM |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T745 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVR |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T109 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LtIVDtGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P07900 | Y627 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | TANMERIMKAQALRDNstMGyMAAKKHLEINPDHsIIEtLR |
| P07942 | S1294 | Sugiyama | LAMB1 | TTSQSNSTAKELDSLQTEAEsLDNtVKELAEQLEFIKNSDI |
| P07942 | T1298 | Sugiyama | LAMB1 | SNSTAKELDSLQTEAEsLDNtVKELAEQLEFIKNSDIRGAL |
| P08134 | T60 | Sugiyama | RHOC ARH9 ARHC | ENYIADIEVDGKQVELALWDtAGQEDYDRLRPLSYPDTDVI |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T104 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LtLVDtGIGMtKADLINNLGtIAKSGtKAFMEALQAGADIS |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | T616 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIVE |
| P08708 | T102 | Sugiyama | RPS17 RPS17L | DNyVPEVsALDQEIIEVDPDtKEMLKLLDFGsLsNLQVtQP |
| P08758 | S37 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAF |
| P08758 | S46 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | KAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGRDLL |
| P08758 | T33 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | PGFDERADAEtLRKAMKGLGtDEEsILtLLtsRsNAQRQEI |
| P08758 | T43 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | tLRKAMKGLGtDEEsILtLLtsRsNAQRQEISAAFKTLFGR |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09104 | S40 | Sugiyama | ENO2 | VEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGK |
| P09104 | T41 | Sugiyama | ENO2 | EVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKG |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09923 | T182 | Sugiyama | ALPI | VGVVTTTRVQHAsPAGtyAHtVNRNWysDADMPASARQEGC |
| P09972 | T123 | Sugiyama | ALDOC ALDC | IVVGIKVDKGVVPLAGtDGEtttQGLDGLsERCAQYKKDGA |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P0DPH7 | T334 | Sugiyama | TUBA3C TUBA2 | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P0DPH7 | T56 | Sugiyama | TUBA3C TUBA2 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10412 | T45 | Sugiyama | H1-4 H1F4 HIST1H1E | RKsAGAAKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10412 | T96 | Sugiyama | H1-4 H1F4 HIST1H1E | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P10412 | T99 | Sugiyama | H1-4 H1F4 HIST1H1E | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P10412 | Y71 | Sugiyama | H1-4 H1F4 HIST1H1E | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P10809 | S247 | Sugiyama | HSPD1 HSP60 | yFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEIANAH |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | T428 | Sugiyama | HSPD1 HSP60 | GtsDVEVNEKKDRVtDALNAtRAAVEEGIVLGGGCALLRCI |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11047 | S942 | Sugiyama | LAMC1 LAMB2 | GFYNLQSGQGCERCDCHALGstNGQCDIRTGQCECQPGITG |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T586 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DKQKILDKCNEIINWLDKNQtAEKEEFEHQQKELEKVCNPI |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12109 | S201 | Sugiyama | COL6A1 | HLGVKVFSVAITPDHLEPRLsIIAtDHTYRRNFTAADWGQS |
| P12109 | T205 | Sugiyama | COL6A1 | KVFSVAITPDHLEPRLsIIAtDHTYRRNFTAADWGQSRDAE |
| P12814 | T340 | Sugiyama | ACTN1 | RRLHKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRM |
| P12814 | T343 | Sugiyama | ACTN1 | HKPPKVQEKCQLEINFNtLQtKLRLsNRPAFMPsEGRMVSD |
| P13667 | T380 | Sugiyama | PDIA4 ERP70 ERP72 | PEKFQSKYEPRSHMMDVQGstQDsAIKDFVLKyALPLVGHR |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P13929 | S40 | Sugiyama | ENO3 | VEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGK |
| P13929 | T41 | Sugiyama | ENO3 | EVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKG |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P13987 | T76 | Sugiyama | CD59 MIC11 MIN1 MIN2 MIN3 MSK21 | AGLQVYNKCWKFEHCNFNDVtTRLRENELtyyCCKKDLCNF |
| P14314 | S445 | Sugiyama | PRKCSH G19P1 | YRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKy |
| P14314 | S451 | Sugiyama | PRKCSH G19P1 | KLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQGtGC |
| P14314 | S478 | Sugiyama | PRKCSH G19P1 | DKFSAMKyEQGtGCWQGPNRstTVRLLCGKEtMVtStTEPS |
| P14314 | T134 | Sugiyama | PRKCSH G19P1 | NtCKEKGRKEREsLQQMAEVtREGFRLKKILIEDWKKAREE |
| P14314 | T444 | Sugiyama | PRKCSH G19P1 | VYRLCPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMK |
| P14314 | T448 | Sugiyama | PRKCSH G19P1 | CPFKLVSQKPKLGGsPtsLGtWGsWIGPDHDKFSAMKyEQG |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | S55 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | IDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMNVARLN |
| P14618 | S77 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sVEtLKEMIKsGMNVARLNFsHGtHEyHAEtIKNVRtAtEs |
| P14618 | T41 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | AMADTFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtL |
| P14618 | T45 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | TFLEHMCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMI |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14618 | T87 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sGMNVARLNFsHGtHEyHAEtIKNVRtAtEsFAsDPILyRP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P14625 | S64 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDDEVVQREEEAIQLDGLNAsQIRELREKSEKFAFQAEVNR |
| P14649 | T101 | Sugiyama | MYL6B MLC1SA | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDELKSRR |
| P15531 | T103 | Sugiyama | NME1 NDPKA NM23 | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P15880 | T202 | Sugiyama | RPS2 RPS4 | CKVTGRCGsVLVRLIPAPRGtGIVsAPVPKKLLMMAGIDDC |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15924 | T61 | Sugiyama | DSP | YYSRRGVITDQNsDGyCQtGtMsRHQNQNTIQELLQNCSDC |
| P16401 | T102 | Sugiyama | H1-5 H1F5 HIST1H1B | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16401 | T99 | Sugiyama | H1-5 H1F5 HIST1H1B | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16402 | T100 | Sugiyama | H1-3 H1F3 HIST1H1D | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEGKPK |
| P16402 | T46 | Sugiyama | H1-3 H1F3 HIST1H1D | KAGATAGKRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | T97 | Sugiyama | H1-3 H1F3 HIST1H1D | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEG |
| P16402 | Y72 | Sugiyama | H1-3 H1F3 HIST1H1D | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | T45 | Sugiyama | H1-2 H1F2 HIST1H1C | AKKAGGtPRKAsGPPVsELItKAVAASKERsGVsLAALKKA |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | T96 | Sugiyama | H1-2 H1F2 HIST1H1C | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16403 | T99 | Sugiyama | H1-2 H1F2 HIST1H1C | RIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEAKPK |
| P16403 | Y71 | Sugiyama | H1-2 H1F2 HIST1H1C | SKERsGVsLAALKKALAAAGyDVEKNNSRIKLGLKsLVsKG |
| P17066 | T49 | Sugiyama | HSPA6 HSP70B' | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18621 | T151 | Sugiyama | RPL17 | RAHGRINPyMssPCHIEMILtEKEQIVPKPEEEVAQKKKIS |
| P18621 | T79 | Sugiyama | RPL17 | PFRRYNGGVGRCAQAKQWGWtQGRWPKKSAEFLLHMLKNAE |
| P18621 | Y139 | Sugiyama | RPL17 | VNKAPKMRRRTYRAHGRINPyMssPCHIEMILtEKEQIVPK |
| P18669 | S152 | Sugiyama | PGAM1 PGAMA CDABP0006 | FysNIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIV |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T146 | Sugiyama | PGAM1 PGAMA CDABP0006 | MEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIARALPF |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S356 | Sugiyama | NCL | LAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKVFGNEI |
| P19338 | S532 | Sugiyama | NCL | IKVPQNQNGKSKGyAFIEFAsFEDAKEALNSCNKREIEGRA |
| P19338 | Y351 | Sugiyama | NCL | FAKNDLAVVDVRIGMTRKFGyVDFEsAEDLEKALELtGLKV |
| P19338 | Y525 | Sugiyama | NCL | VFEKATFIKVPQNQNGKSKGyAFIEFAsFEDAKEALNSCNK |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P20073 | S216 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | KAMKGFGtDEQAIVDVVANRsNDQRQKIKAAFKTSYGKDLI |
| P20073 | T203 | Sugiyama | ANXA7 ANX7 SNX OK/SW-cl.95 | ANFDAIRDAEILRKAMKGFGtDEQAIVDVVANRsNDQRQKI |
| P20290 | T131 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsIL |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20290 | T135 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLG |
| P20290 | T140 | Sugiyama | BTF3 NACB OK/SW-cl.8 | NPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQLGADsLt |
| P21796 | S193 | SIGNOR|EPSD|PSP | VDAC1 VDAC | YKTDEFQLHTNVNDGTEFGGsIYQKVNKKLETAVNLAWtAG |
| P22061 | S133 | Sugiyama | PCMT1 | KELVDDsVNNVRKDDPTLLssGRVQLVVGDGRMGYAEEAPY |
| P22314 | T682 | Sugiyama | UBA1 A1S9T UBE1 | NVNQyLtDPKFVERtLRLAGtQPLEVLEAVQRSLVLQRPQT |
| P22392 | T103 | Sugiyama | NME2 NM23B | VVKTGRVMLGEtNPADsKPGtIRGDFCIQVGRNIIHGsDsV |
| P22492 | Y75 | Sugiyama | H1-6 H1FT H1T HIST1H1T | SQERVGMSLVALKKALAAAGyDVEKNNSRIKLSLKSLVNKG |
| P22626 | S212 | Sugiyama | HNRNPA2B1 HNRPA2B1 | EMQEVQssRsGRGGNFGFGDsRGGGGNFGPGPGsNFRGGsD |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23396 | T242 | Sugiyama | RPS3 OK/SW-cl.26 | PIsEQKGGKPEPPAMPQPVPtA___________________ |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T526 | Sugiyama | MSN | EERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHA |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T107 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | HKKVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILF |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27348 | S45 | Sugiyama | YWHAQ | CMKAVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSI |
| P27348 | Y48 | Sugiyama | YWHAQ | AVtEQGAELsNEERNLLsVAyKNVVGGRRSAWRVIsSIEQK |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | S78 | Sugiyama | CALR CRTC | GDEEKDKGLQTSQDARFyALsAsFEPFSNKGQTLVVQFTVK |
| P27797 | S80 | Sugiyama | CALR CRTC | EEKDKGLQTSQDARFyALsAsFEPFSNKGQTLVVQFTVKHE |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P28482 | T351 | Sugiyama | MAPK1 ERK2 PRKM1 PRKM2 | FDMELDDLPKEKLKELIFEEtARFQPGYRS___________ |
| P29401 | S439 | Sugiyama | TKT | VSIGEDGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVE |
| P29401 | T342 | Sugiyama | TKT | GQALAKLGHAsDRIIALDGDtKNstFsEIFKKEHPDRFIEC |
| P29401 | T444 | Sugiyama | TKT | DGPSQMALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANT |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S74 | Sugiyama | EEF1D EF1D | RENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQsL |
| P29692 | T73 | Sugiyama | EEF1D EF1D | ARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVENQs |
| P30041 | T192 | Sugiyama | PRDX6 AOP2 KIAA0106 | EKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGVFtKELP |
| P30041 | T48 | Sugiyama | PRDX6 AOP2 KIAA0106 | FLGDSWGILFSHPRDFtPVCttELGRAAKLAPEFAKRNVKL |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T18 | Sugiyama | RPL12 | ___MPPKFDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLs |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S60 | Sugiyama | PEBP1 PBP PEBP | VLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPK |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | T437 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KELGEKLsKDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsP |
| P31327 | S564 | Sugiyama | CPS1 | TEDRQLFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPV |
| P31327 | S569 | Sugiyama | CPS1 | LFSDKLNEINEKIAPsFAVEsIEDALKAADTIGyPVMIRSA |
| P31327 | T326 | Sugiyama | CPS1 | AKTYKMSMANRGQNQPVLNItNKQAFITAQNHGYALDNTLP |
| P31327 | T45 | Sugiyama | CPS1 | AHQKWKFSRPGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPS |
| P31327 | T54 | Sugiyama | CPS1 | PGIRLLSVKAQtAHIVLEDGtKMKGYSFGHPSSVAGEVVFN |
| P31943 | S281 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | GRDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAt |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31943 | T282 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | RDLNyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtE |
| P31943 | T286 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDIy |
| P31946 | S47 | Sugiyama | YWHAB | AMKAVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P31946 | Y50 | Sugiyama | YWHAB | AVtEQGHELsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P31947 | S45 | Sugiyama | SFN HME1 | FMKGAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsI |
| P31947 | Y48 | Sugiyama | SFN HME1 | GAVEKGEELsCEERNLLsVAyKNVVGGQRAAWRVLSsIEQK |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P33176 | S950 | Sugiyama | KIF5B KNS KNS1 | PAAsPtHPSAIRGGGAFVQNsQPVAVRGGGGKQV_______ |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35241 | T425 | Sugiyama | RDX | KQAADQMKNQEQLAAELAEFtAKIALLEEAKKKKEEEATEW |
| P35269 | T154 | Sugiyama | GTF2F1 RAP74 | AFEAFPVHNWYNFTPLARHRtLtAEEAEEEWERRNKVLNHF |
| P35579 | S1154 | Sugiyama | MYH9 | KRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNILKK |
| P35579 | S1308 | Sugiyama | MYH9 | LLsQsDSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLs |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | S876 | Sugiyama | MYH9 | KVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAETELC |
| P35579 | T1151 | Sugiyama | MYH9 | EKQKRDLGEELEALKtELEDtLDstAAQQELRSKREQEVNI |
| P35579 | T1208 | Sugiyama | MYH9 | QEMRQKHsQAVEELAEQLEQtKRVKANLEKAKQtLENERGE |
| P35579 | T1313 | Sugiyama | MYH9 | DSKSSKLTKDFsALEsQLQDtQELLQEENRQKLsLstKLKQ |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35579 | T873 | Sugiyama | MYH9 | ELVKVREKQLAAENRLTEMEtLQsQLMAEKLQLQEQLQAET |
| P35609 | T347 | Sugiyama | ACTN2 | RRKHKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKM |
| P35609 | T350 | Sugiyama | ACTN2 | HKPPKVQEKCQLEINFNtLQtKLRISNRPAFMPSEGKMVSD |
| P36578 | S255 | Sugiyama | RPL4 RPL1 | LNILKLAPGGHVGRFCIWtEsAFRKLDELyGtWRKAAsLKs |
| P36578 | S272 | Sugiyama | RPL4 RPL1 | WtEsAFRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRI |
| P36578 | S275 | Sugiyama | RPL4 RPL1 | sAFRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKs |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T253 | Sugiyama | RPL4 RPL1 | sKLNILKLAPGGHVGRFCIWtEsAFRKLDELyGtWRKAAsL |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36578 | T69 | Sugiyama | RPL4 RPL1 | RQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGGtHRsGQ |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P36578 | Y277 | Sugiyama | RPL4 RPL1 | FRKLDELyGtWRKAAsLKsNyNLPMHKMINtDLsRILKsPE |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S145 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | VQRTLMNLGGLAVARDDGLFsGDPNWFPKKSKENPRNFsDN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38117 | T172 | Sugiyama | ETFB FP585 | QVTLEGDKLKVEREIDGGLEtLRLKLPAVVTADLRLNEPRy |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T36 | Sugiyama | RPS19 | RALAAFLKKSGKLKVPEWVDtVKLAKHKELAPyDENWFytR |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40337 | S168 | SIGNOR|EPSD|PSP | VHL | FANITLPVYTLKERCLQVVRsLVKPENyRRLDIVRsLyEDL |
| P40337 | S183 | EPSD|PSP | VHL | LQVVRsLVKPENyRRLDIVRsLyEDLEDHPNVQKDLERLtQ |
| P40337 | T100 | EPSD|PSP | VHL | sPRVVLPVWLNFDGEPQPYPtLPPGtGRRIHsyRGHLWLFR |
| P40337 | T105 | EPSD|PSP | VHL | LPVWLNFDGEPQPYPtLPPGtGRRIHsyRGHLWLFRDAGTH |
| P40337 | T202 | EPSD|PSP | VHL | RsLyEDLEDHPNVQKDLERLtQERIAHQRMGD_________ |
| P40337 | Y112 | EPSD|PSP | VHL | DGEPQPYPtLPPGtGRRIHsyRGHLWLFRDAGTHDGLLVNQ |
| P40337 | Y175 | EPSD|PSP | VHL | VYTLKERCLQVVRsLVKPENyRRLDIVRsLyEDLEDHPNVQ |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P40855 | S147 | Sugiyama | PEX19 HK33 PXF OK/SW-cl.22 | SCLKETLSGLAKNATDLQNssMsEEELTKAMEGLGMDEGDG |
| P41091 | T120 | Sugiyama | EIF2S3 EIF2G | ECyRSCGsstPDEFPtDIPGtKGNFKLVRHVSFVDCPGHDI |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P42766 | T59 | Sugiyama | RPL35 | GAASKLsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyK |
| P42766 | T64 | Sugiyama | RPL35 | LsKIRVVRKSIARVLtVINQtQKENLRKFYKGKKyKPLDLR |
| P43490 | T179 | Sugiyama | NAMPT PBEF PBEF1 | ITVATNSREQKKILAKyLLEtsGNLDGLEyKLHDFGyRGVS |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46776 | Y52 | Sugiyama | RPL27A | RGNAGGLHHHRINFDKyHPGyFGKVGMKHYHLKRNQsFCPt |
| P46779 | T81 | Sugiyama | RPL28 | VVVIKRRSGQRKPAtsyVRttINKNARAtLsSIRHMIRKNK |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P47756 | S192 | Sugiyama | CAPZB | TVMLWLQTNKSGsGtMNLGGsLtRQMEKDEtVsDCsPHIAN |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P47914 | S26 | Sugiyama | RPL29 | NHTTHNQSRKWHRNGIKKPRsQRYEsLKGVDPKFLRNMRFA |
| P47914 | S31 | Sugiyama | RPL29 | NQSRKWHRNGIKKPRsQRYEsLKGVDPKFLRNMRFAKKHNK |
| P47914 | T155 | Sugiyama | RPL29 | AQAAAPAsVPAQAPKRtQAPtKAsE________________ |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P48163 | S336 | SIGNOR|PSP | ME1 | ALEKEGLPKEKAIKKIWLVDsKGLIVKGRASLTQEKEKFAH |
| P48643 | T269 | Sugiyama | CCT5 CCTE KIAA0098 | AILTCPFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMI |
| P48643 | Y274 | Sugiyama | CCT5 CCTE KIAA0098 | PFEPPKPKTKHKLDVtsVEDyKALQKYEKEKFEEMIQQIKE |
| P48741 | T49 | Sugiyama | HSPA7 HSP70B | EILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHNtV |
| P49327 | T2215 | Sugiyama | FASN FAS | DEAsELACPtPKEDGLAQQQtQLNLRSLLVNPEGPtLMRLN |
| P49327 | T309 | Sugiyama | FASN FAS | yIEAHGtGTKVGDPQELNGItRALCAtRQEPLLIGsTKSNM |
| P49915 | T330 | Sugiyama | GMPS | LPIsDEDRtPRKRISKTLNMttsPEEKRKIIGDTFVKIANE |
| P50395 | T407 | Sugiyama | GDI2 RABGDIB | LVPKDLGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGs |
| P50395 | T412 | Sugiyama | GDI2 RABGDIB | LGtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFE |
| P50395 | T413 | Sugiyama | GDI2 RABGDIB | GtEsQIFIsRTyDAttHFEttCDDIKNIYKRMtGsEFDFEE |
| P50897 | T261 | Sugiyama | PPT1 CLN1 PPT | SEWFGFYRsGQAKEtIPLQEtsLytQDRLGLKEMDNAGQLV |
| P51659 | T191 | Sugiyama | HSD17B4 EDH17B4 SDR8C1 | LLGLANSLAIEGRKsNIHCNtIAPNAGsRMTQTVMPEDLVE |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P51991 | S370 | Sugiyama | HNRNPA3 HNRPA3 | sFGGRssGsPyGGGyGsGGGsGGyGsRRF____________ |
| P51991 | S375 | Sugiyama | HNRNPA3 HNRPA3 | ssGsPyGGGyGsGGGsGGyGsRRF_________________ |
| P52272 | S528 | Sugiyama | HNRNPM HNRPM NAGR1 | IERMGsGVERMGPAIERMGLsMERMVPAGMGAGLERMGPVM |
| P53634 | T431 | Sugiyama | CTSC CPPI | GYGTDSASGMDYWIVKNsWGtGWGENGyFRIRRGtDECAIE |
| P53999 | S10 | Sugiyama | SUB1 PC4 RPO2TC1 | ___________MPKSKELVsssssGsDsDsEVDKKLKRKKQ |
| P54105 | T34 | Sugiyama | CLNS1A CLCI ICLN | EGLLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGF |
| P54105 | T36 | Sugiyama | CLNS1A CLCI ICLN | LLRQQPDTEAVLNGKGLGtGtLyIAEsRLSWLDGsGLGFSL |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55010 | T235 | Sugiyama | EIF5 | RMDEISDHAKVLtLsDDLERtIEERVNILFDFVKKKKEEGV |
| P55036 | T264 | Sugiyama | PSMD4 MCB1 | AEAGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEE |
| P55060 | S931 | Sugiyama | CSE1L CAS XPO2 | KKEHDPVGQMVNNPKIHLAQsLHKLSTACPGRVPSMVSTSL |
| P55209 | S69 | Sugiyama | NAP1L1 NRP | LAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQVKCA |
| P55209 | T269 | Sugiyama | NAP1L1 NRP | GPEIMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVT |
| P55209 | T272 | Sugiyama | NAP1L1 NRP | IMGCTGCQIDWKKGKNVtLKtIKKKQKHKGRGTVRTVTKTV |
| P55209 | T64 | Sugiyama | NAP1L1 NRP | QNPQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNL |
| P55209 | Y66 | Sugiyama | NAP1L1 NRP | PQILAALQERLDGLVEtPtGyIEsLPRVVKRRVNALKNLQV |
| P57053 | S39 | Sugiyama | H2BC12L H2BFS H2BS1 | VTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P57721 | T159 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | sQCGsLIGKGGSKIKEIREstGAQVQVAGDMLPNstERAVT |
| P57721 | T174 | Sugiyama | PCBP3 PCBP3-OT1 PCBP3OT | EIREstGAQVQVAGDMLPNstERAVTISGTPDAIIQCVKQI |
| P58546 | T108 | Sugiyama | MTPN | LSKGADKTVKGPDGLTAFEAtDNQAIKALLQ__________ |
| P58876 | S39 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| P60174 | S106 | Sugiyama | TPI1 TPI | DCGAtWVVLGHsERRHVFGEsDELIGQKVAHALAEGLGVIA |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S97 | Sugiyama | TPI1 TPI | GEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELIGQKVAHA |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T22 | Sugiyama | MYL6 | CDFTEDQTAEFKEAFQLFDRtGDGKILysQCGDVMRALGQN |
| P60660 | T44 | Sugiyama | MYL6 | DGKILysQCGDVMRALGQNPtNAEVLKVLGNPKsDEMNVKV |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T106 | Sugiyama | ACTB | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T303 | Sugiyama | ACTB | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P60709 | T304 | Sugiyama | ACTB | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61204 | S147 | Sugiyama | ARF3 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61289 | T99 | Sugiyama | PSME3 | LDGPTYKKRRLDECEEAFQGtKVFVMPNGMLKSNQQLVDII |
| P61313 | T80 | Sugiyama | RPL15 EC45 TCBAP0781 | VIyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQs |
| P61313 | Y81 | Sugiyama | RPL15 EC45 TCBAP0781 | IyRIRVRRGGRKRPVPKGAtyGKPVHHGVNQLKFARsLQsV |
| P61353 | S34 | Sugiyama | RPL27 | LAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKVT |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61586 | T60 | Sugiyama | RHOA ARH12 ARHA RHO12 | ENyVADIEVDGKQVELALWDtAGQEDyDRLRPLSYPDTDVI |
| P61978 | S401 | Sugiyama | HNRNPK HNRPK | GDLGGPIIttQVtIPKDLAGsIIGKGGQRIKQIRHEsGAsI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y72 | Sugiyama | HNRNPK HNRPK | KNAGAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISA |
| P61981 | S46 | Sugiyama | YWHAG | AMKNVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSI |
| P61981 | Y49 | Sugiyama | YWHAG | NVtELNEPLsNEERNLLsVAyKNVVGARRSsWRVIsSIEQK |
| P62081 | S174 | Sugiyama | RPS7 | IKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL |
| P62081 | T172 | Sugiyama | RPS7 | RLIKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEF |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62258 | S46 | Sugiyama | YWHAE | SMKKVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssI |
| P62258 | Y49 | Sugiyama | YWHAE | KVAGMDVELTVEERNLLsVAyKNVIGARRASWRIIssIEQK |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62266 | T34 | Sugiyama | RPS23 | RSHRRDQKWHDKQYKKAHLGtALKANPFGGAsHAKGIVLEK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y34 | Sugiyama | RPS29 | FGQGSRSCRVCSNRHGLIRKyGLNMCRQCFRQYAKDIGFIK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T28 | Sugiyama | RPS11 | RAyQKQPtIFQNKKRVLLGEtGKEKLPRYYKNIGLGFKtPK |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62745 | T60 | Sugiyama | RHOB ARH6 ARHB | ENYVADIEVDGKQVELALWDtAGQEDYDRLRPLSYPDTDVI |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62753 | S6 | Sugiyama | RPS6 OK/SW-cl.2 | _______________MKLNIsFPAtGCQKLIEVDDERKLRt |
| P62753 | T10 | Sugiyama | RPS6 OK/SW-cl.2 | ___________MKLNIsFPAtGCQKLIEVDDERKLRtFyEK |
| P62807 | S39 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | VTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIssKA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62851 | T113 | Sugiyama | RPS25 | sKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA________ |
| P62851 | Y109 | Sugiyama | RPS25 | QELLsKGLIKLVSKHRAQVIytRNtKGGDAPAAGEDA____ |
| P62857 | T21 | Sugiyama | RPS28 | MDTSRVQPIKLARVTKVLGRtGsQGQCtQVRVEFMDDtsRs |
| P62857 | T38 | Sugiyama | RPS28 | LGRtGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtL |
| P62899 | T107 | Sugiyama | RPL31 | RLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN__ |
| P62899 | T112 | Sugiyama | RPL31 | RNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN_______ |
| P62899 | T113 | Sugiyama | RPL31 | NEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62899 | Y103 | Sugiyama | RPL31 | RIRVRLSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVD |
| P62899 | Y108 | Sugiyama | RPL31 | LSRKRNEDEDsPNKLytLVtyVPVttFKNLQtVNVDEN___ |
| P62899 | Y25 | Sugiyama | RPL31 | KKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRA |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T15 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______MGVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGK |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P62979 | Y140 | Sugiyama | RPS27A UBA80 UBCEP1 | ECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPEDK____ |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63104 | S45 | Sugiyama | YWHAZ | CMKsVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssI |
| P63104 | T194 | Sugiyama | YWHAZ | FSVFYYEILNsPEKACSLAKtAFDEAIAELDtLsEEsyKDs |
| P63104 | T30 | Sugiyama | YWHAZ | AKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAyKN |
| P63104 | Y48 | Sugiyama | YWHAZ | sVtEQGAELsNEERNLLsVAyKNVVGARRssWRVVssIEQK |
| P63167 | T26 | Sugiyama | DYNLL1 DLC1 DNCL1 DNCLC1 HDLC1 | AVIKNADMsEEMQQDsVECAtQALEKYNIEKDIAAHIKKEF |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T106 | Sugiyama | ACTG1 ACTG | WHHtFyNELRVAPEEHPVLLtEAPLNPKANREKMTQIMFET |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T303 | Sugiyama | ACTG1 ACTG | MKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPs |
| P63261 | T304 | Sugiyama | ACTG1 ACTG | KCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPst |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T126 | Sugiyama | YBX1 NSEP1 YB1 | GEtVEFDVVEGEKGAEAANVtGPGGVPVQGsKYAADRNHYR |
| P67809 | T271 | Sugiyama | YBX1 NSEP1 YB1 | RQRQPREDGNEEDKENQGDEtQGQQPPQRRyRRNFNYRRRR |
| P67936 | T241 | Sugiyama | TPM4 | EEKLAQAKEENVGLHQtLDQtLNELNCI_____________ |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P68363 | T334 | Sugiyama | TUBA1B | ACCLLyRGDVVPKDVNAAIAtIKtKRsIQFVDWCPTGFKVG |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P68363 | T56 | Sugiyama | TUBA1B | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68363 | Y83 | Sugiyama | TUBA1B | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P68431 | T46 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P68431 | Y42 | Sugiyama | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | ATKAARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELL |
| P78371 | T103 | Sugiyama | CCT2 99D8.1 CCTB | VLVDMSRVQDDEVGDGTTsVtVLAAELLREAESLIAKKIHP |
| P78371 | T474 | Sugiyama | CCT2 99D8.1 CCTB | AGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAILGIT |
| P78371 | T64 | Sugiyama | CCT2 99D8.1 CCTB | GPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVL |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | T52 | Sugiyama | RPL24 | LNAKCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRT |
| P83731 | Y55 | Sugiyama | RPL24 | KCEsAFLSKRNPRQINWtVLyRRKHKKGQsEEIQKKRTRRA |
| P83881 | S79 | Sugiyama | RPL36A RPL44 GIG15 MIG6 | KAKTTKKIVLRLECVEPNCRsKRMLAIKRCKHFELGGDKKR |
| P84077 | S147 | Sugiyama | ARF1 | KQDLPNAMNAAEITDKLGLHsLRHRNWYIQATCATSGDGLY |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S13 | Sugiyama | RPL19 | ________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEIA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P84098 | Y124 | Sugiyama | RPL19 | RLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHIHK |
| P84243 | T46 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| P84243 | Y42 | Sugiyama | H3-3A H3.3A H3F3 H3F3A PP781; H3-3B H3.3B H3F3B | ATKAARKsAPsTGGVKKPHRyRPGtVALREIRRYQKstELL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q02539 | T102 | Sugiyama | H1-1 H1F1 HIST1H1A | RIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVETKPG |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02539 | T99 | Sugiyama | H1-1 H1F1 HIST1H1A | NNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVET |
| Q02539 | Y74 | Sugiyama | H1-1 H1F1 HIST1H1A | SKERGGVSLAALKKALAAAGyDVEKNNSRIKLGIKsLVsKG |
| Q02818 | S378 | Sugiyama | NUCB1 NUC | EAELNAKAQRLsQETEALGRsQGRLEAQKRELQQAVLHMEQ |
| Q02878 | T213 | Sugiyama | RPL6 TXREB1 | FVIAtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIF |
| Q02878 | Y216 | Sugiyama | RPL6 TXREB1 | AtsTKIDISNVKIPKHLtDAyFKKKKLRKPRHQEGEIFDtE |
| Q04637 | T1119 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GGSGAKPSDAAsEAARPAtstLNRFsALQQAVPtEsTDNRR |
| Q04760 | T35 | Sugiyama | GLO1 | AALSCCSDADPSTKDFLLQQtMLRVKDPKKSLDFyTRVLGM |
| Q04917 | S46 | Sugiyama | YWHAH YWHA1 | AMKAVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSI |
| Q04917 | Y49 | Sugiyama | YWHAH YWHA1 | AVtELNEPLsNEDRNLLsVAyKNVVGARRSsWRVIsSIEQK |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q07020 | S130 | Sugiyama | RPL18 | RSRILRAGGKILtFDQLALDsPKGCGtVLLsGPRKGREVYR |
| Q07020 | T122 | Sugiyama | RPL18 | ALRVTSRARSRILRAGGKILtFDQLALDsPKGCGtVLLsGP |
| Q08043 | T354 | Sugiyama | ACTN3 | RRLHKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKL |
| Q08043 | T357 | Sugiyama | ACTN3 | HKPPRIQEKCQLEINFNtLQtKLRLSHRPAFMPSEGKLVSD |
| Q12906 | T300 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | ASGIVMPDGSGIYDPCEKEAtDAIGHLDRQQREDItQsAQH |
| Q13098 | S483 | Sugiyama | GPS1 COPS1 CSN1 | QIHVKsPPREGsQGELtPANsQsRMstNM____________ |
| Q13442 | T18 | Sugiyama | PDAP1 HASPP28 | ___MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREEE |
| Q13442 | T92 | Sugiyama | PDAP1 HASPP28 | QKRKGVEGLIDIENPNRVAQttKKVtQLDLDGPKELSRRER |
| Q13442 | T93 | Sugiyama | PDAP1 HASPP28 | KRKGVEGLIDIENPNRVAQttKKVtQLDLDGPKELSRRERE |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14103 | S271 | Sugiyama | HNRNPD AUF1 HNRPD | KCEIKVAMSKEQyQQQQQWGsRGGFAGRARGRGGGPSQNWN |
| Q14103 | T91 | Sugiyama | HNRNPD AUF1 HNRPD | sKNEEDEGHsNssPRHsEAAtAQREEWKMFIGGLSWDTTKK |
| Q14157 | S254 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSAWRtAtEEWGtEDWNEDLsEtKIFtAsNVssVPLPAENV |
| Q14157 | T246 | Sugiyama | UBAP2L KIAA0144 NICE4 | GHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtAsNVss |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14204 | T1307 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FGRLKDDREKCAKAKEALELtDtGLLsGSEERVQVALEELQ |
| Q14204 | T1309 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | RLKDDREKCAKAKEALELtDtGLLsGSEERVQVALEELQDL |
| Q14204 | T695 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | NHVEGQKLKQDGDsFRMKLNtQEIFDDWARKVQQRNLGVSG |
| Q14320 | S62 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | KSNIDKKFsAHyDAVEAELKsstVGLVtLNDMKAKQEALVK |
| Q14320 | T69 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | FsAHyDAVEAELKsstVGLVtLNDMKAKQEALVKEREKQLA |
| Q14444 | T303 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | YTEQSEVESTEYVNRQFMAEtQFtsGEKEQVDEWTVETVEV |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | T109 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LTIVDTGIGMTKADLINNLGtIAKSGtKAFMEALQAGADIS |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q15003 | T729 | Sugiyama | NCAPH BRRN BRRN1 CAPH KIAA0074 | PLAFACLLHLANEKNLKLEGtEDLsDVLVRQGD________ |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | S69 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | LPFNTVQGDIDAIFKDLsIRsVRLVRDKDTDKFKGFCyVEF |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15084 | S263 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | FQKGEsPVDyDGGRTRsDIVsRALDLFSDNAPPPELLEIIN |
| Q15181 | T245 | Sugiyama | PPA1 IOPPP PP | DHWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDA |
| Q15181 | T246 | Sugiyama | PPA1 IOPPP PP | HWKALVTKKTNGKGIsCMNttLsEsPFKCDPDAARAIVDAL |
| Q15293 | T101 | Sugiyama | RCN1 RCN | KERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNVA |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T163 | Sugiyama | RCN1 RCN | AtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAADLNGD |
| Q15293 | Y145 | Sugiyama | RCN1 RCN | KDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtFK |
| Q15365 | T127 | Sugiyama | PCBP1 | TQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15365 | T142 | Sugiyama | PCBP1 | EIREstGAQVQVAGDMLPNstERAITIAGVPQSVTECVKQI |
| Q15366 | T127 | Sugiyama | PCBP2 | sQCGsLIGKGGCKIKEIREstGAQVQVAGDMLPNstERAIT |
| Q15366 | T142 | Sugiyama | PCBP2 | EIREstGAQVQVAGDMLPNstERAITIAGIPQSIIECVKQI |
| Q15369 | T41 | Sugiyama | ELOC TCEB1 | LISSDGHEFIVKREHALtsGtIKAMLSGPGQFAENETNEVN |
| Q15417 | T224 | Sugiyama | CNN3 | ISLQMGTNKGAsQAGMLAPGtRRDIYDQKLTLQPVDNSTIS |
| Q16576 | T10 | Sugiyama | RBBP7 RBAP46 | ___________MAsKEMFEDtVEERVINEEYKIWKKNTPFL |
| Q16658 | T239 | Sugiyama | FSCN1 FAN1 HSN SNL | GKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALEQs |
| Q16695 | T46 | Sugiyama | H3-4 H3FT HIST3H3 | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q16695 | Y42 | Sugiyama | H3-4 H3FT HIST3H3 | ATKVARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELL |
| Q16775 | T291 | Sugiyama | HAGH GLO2 HAGH1 | PFMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD___ |
| Q16775 | T292 | Sugiyama | HAGH GLO2 HAGH1 | FMRVREKTVQQHAGETDPVttMRAVRREKDQFKMPRD____ |
| Q27J81 | T1039 | Sugiyama | INF2 C14orf151 C14orf173 | PAGDPVGSTRCPASEPGLDAtTASESRGWDLVDAVtPGPQP |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF7 | T489 | Sugiyama | HSP90AB3P HSP90BC | YGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIME |
| Q58FF8 | T104 | Sugiyama | HSP90AB2P HSP90BB | LTLVDTGIGMTKADLINNLGtIAKFQDQTEYLEEMQVKEVV |
| Q5QJE6 | S703 | Sugiyama | DNTTIP2 ERBP TDIF2 | GFPKyFQIGtIVDNPADFyHsRIPKKQRKRTIVEELLADSE |
| Q5QJE6 | T692 | Sugiyama | DNTTIP2 ERBP TDIF2 | PKRFYKKNDRDGFPKyFQIGtIVDNPADFyHsRIPKKQRKR |
| Q5QNW6 | S39 | Sugiyama | H2BC18 HIST2H2BF | VTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q5SW79 | T870 | Sugiyama | CEP170 FAM68A KAB KIAA0470 | IELIPHINKQTsstPssLALtsAsRIRERsEsLDPDssMDT |
| Q5T3I0 | T271 | Sugiyama | GPATCH4 GPATC4 | KVsDEREGTTKGNEKEDAAGtsGLGELNSREQtNQSLRKGK |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6NXT2 | T45 | Sugiyama | H3-5 H3F3C | AARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q6NXT2 | Y41 | Sugiyama | H3-5 H3F3C | LATKAARKSTPSTCGVKPHRyRPGtVALREIRRYQKstELL |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6PEY2 | T334 | Sugiyama | TUBA3E | ACCMLYRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6PEY2 | T56 | Sugiyama | TUBA3E | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVVD |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6UXH1 | T300 | Sugiyama | CRELD2 UNQ185/PRO211 | GYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSYVCVCP |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71DI3 | T46 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELLIRKL |
| Q71DI3 | Y42 | Sugiyama | H3C15 HIST2H3A; H3C14 H3F2 H3FM HIST2H3C; H3C13 HIST2H3D | ATKAARKsAPATGGVKKPHRyRPGtVALREIRRYQKstELL |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q71U36 | T334 | Sugiyama | TUBA1A TUBA3 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71U36 | T56 | Sugiyama | TUBA1A TUBA3 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71U36 | Y83 | Sugiyama | TUBA1A TUBA3 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7KZF4 | T134 | Sugiyama | SND1 TDRD11 | LGKDTNGENIAEsLVAEGLAtRREGMRANNPEQNRLsECEE |
| Q7Z2W4 | T363 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | NPGstyLASNsTsAPNWKsLtsWtNDQGARRKtVFsPtLPA |
| Q7Z417 | S652 | Sugiyama | NUFIP2 KIAA1321 PIG1 | NtLLGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsI |
| Q7Z739 | T177 | Sugiyama | YTHDF3 | YPPSSLGRAITDGQAGFGNDtLSKVPGISsIEQGMTGLKIG |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86V81 | T148 | Sugiyama | ALYREF ALY BEF THOC4 | EFGtLKKAAVHYDRsGRsLGtADVHFERKADALKAMKQYNG |
| Q8IX12 | S1075 | Sugiyama | CCAR1 CARP1 DIS | LQLLEEKTDEDEKTILNLENsNKsLsGELREVKKDLsQLQE |
| Q8N129 | T46 | Sugiyama | CNPY4 PSEC0237 UNQ1909/PRO4354 | EEDDDTERLPSKCEVCKLLstELQAELsRtGRsREVLELGQ |
| Q8N129 | T55 | Sugiyama | CNPY4 PSEC0237 UNQ1909/PRO4354 | PSKCEVCKLLstELQAELsRtGRsREVLELGQVLDTGKRKR |
| Q8NBS9 | T264 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KVDCtQHyELCsGNQVRGyPtLLWFRDGKKVDQYKGKRDLE |
| Q8NBS9 | Y262 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | IGKVDCtQHyELCsGNQVRGyPtLLWFRDGKKVDQYKGKRD |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q92598 | T795 | Sugiyama | HSPH1 HSP105 HSP110 KIAA0201 | DQDPVVRAQEIKTKIKELNNtCEPVVTQPKPKIEsPKLERt |
| Q92698 | S572 | EPSD|PSP | RAD54L RAD54A | RAKVVERFNSPSSPDFVFMLsSKAGGCGLNLIGANRLVMFD |
| Q93079 | S39 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q969Q0 | S79 | Sugiyama | RPL36AL | KAKTTKKIVLRLECVEPNCRsKRMLAIKRCKHFELGGDKKR |
| Q96CP2 | T83 | Sugiyama | FLYWCH2 | HCVMsLGVPGPATLAKALLQtHPEAQRAIEAAPQEPEQKRS |
| Q96G46 | T99 | Sugiyama | DUS3L | DGQtADGQtEEAAEPGEQLQtQKRARGQNKGRPHVKPTNYD |
| Q96HE7 | T148 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | IEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSDNFCEA |
| Q96PY6 | S14 | Sugiyama | NEK1 KIAA1901 | _______MEKYVRLQKIGEGsFGKAILVKstEDGRQYVIKE |
| Q96PY6 | S155 | Sugiyama | NEK1 KIAA1901 | FLTKDGtVQLGDFGIARVLNstVELARTCIGTPYYLSPEIC |
| Q96PY6 | S23 | Sugiyama | NEK1 KIAA1901 | KYVRLQKIGEGsFGKAILVKstEDGRQYVIKEINISRMSSK |
| Q96PY6 | S251 | Sugiyama | NEK1 KIAA1901 | LRSLVSQLFKRNPRDRPSVNsILEKGFIAKRIEKFLSPQLI |
| Q96PY6 | S285 | Sugiyama | NEK1 KIAA1901 | FLSPQLIAEEFCLKTFSKFGsQPIPAKRPAsGQNsISVMPA |
| Q96PY6 | S295 | Sugiyama | NEK1 KIAA1901 | FCLKTFSKFGsQPIPAKRPAsGQNsISVMPAQKITKPAAKy |
| Q96PY6 | S299 | Sugiyama | NEK1 KIAA1901 | TFSKFGsQPIPAKRPAsGQNsISVMPAQKITKPAAKyGIPL |
| Q96PY6 | S414 | Sugiyama | NEK1 KIAA1901 | EKERLERINRAREQGWRNVLsAGGsGEVKAPFLGsGGtIAP |
| Q96PY6 | S418 | Sugiyama | NEK1 KIAA1901 | LERINRAREQGWRNVLsAGGsGEVKAPFLGsGGtIAPSsFS |
| Q96PY6 | S428 | Sugiyama | NEK1 KIAA1901 | GWRNVLsAGGsGEVKAPFLGsGGtIAPSsFSsRGQYEHYHA |
| Q96PY6 | S436 | Sugiyama | NEK1 KIAA1901 | GGsGEVKAPFLGsGGtIAPSsFSsRGQYEHYHAIFDQMQQQ |
| Q96PY6 | S439 | Sugiyama | NEK1 KIAA1901 | GEVKAPFLGsGGtIAPSsFSsRGQYEHYHAIFDQMQQQRAE |
| Q96PY6 | T141 | Sugiyama | NEK1 KIAA1901 | DRKILHRDIKSQNIFLTKDGtVQLGDFGIARVLNstVELAR |
| Q96PY6 | T156 | Sugiyama | NEK1 KIAA1901 | LTKDGtVQLGDFGIARVLNstVELARTCIGTPYYLSPEICE |
| Q96PY6 | T24 | Sugiyama | NEK1 KIAA1901 | YVRLQKIGEGsFGKAILVKstEDGRQYVIKEINISRMSSKE |
| Q96PY6 | T431 | Sugiyama | NEK1 KIAA1901 | NVLsAGGsGEVKAPFLGsGGtIAPSsFSsRGQYEHYHAIFD |
| Q96PY6 | Y315 | Sugiyama | NEK1 KIAA1901 | sGQNsISVMPAQKITKPAAKyGIPLAyKKYGDKKLHEKKPL |
| Q96PY6 | Y321 | Sugiyama | NEK1 KIAA1901 | SVMPAQKITKPAAKyGIPLAyKKYGDKKLHEKKPLQKHKQA |
| Q99733 | T24 | Sugiyama | NAP1L4 NAP2 | HsFsDGVPsDsVEAAKNAsNtEKLtDQVMQNPRVLAALQER |
| Q99733 | T28 | Sugiyama | NAP1L4 NAP2 | DGVPsDsVEAAKNAsNtEKLtDQVMQNPRVLAALQERLDNV |
| Q99877 | S39 | Sugiyama | H2BC15 H2BFD HIST1H2BN | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99879 | S39 | Sugiyama | H2BC14 H2BFE HIST1H2BM | INKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q99880 | S39 | Sugiyama | H2BC13 H2BFC HIST1H2BL | VTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIssKA |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BQE3 | T334 | Sugiyama | TUBA1C TUBA6 | ACCLLyRGDVVPKDVNAAIAtIKtKRTIQFVDWCPTGFKVG |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BQE3 | T56 | Sugiyama | TUBA1C TUBA6 | MPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFVDLEPtVID |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BQE3 | Y83 | Sugiyama | TUBA1C TUBA6 | PRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANNy |
| Q9BS26 | T155 | Sugiyama | ERP44 KIAA0573 TXNDC4 UNQ532/PRO1075 | yIRQQKSDPIQEIRDLAEIttLDRSKRNIIGYFEQKDSDNy |
| Q9BSV6 | S93 | Sugiyama | TSEN34 LENG5 SEN34 | RPDSRHHSLALTSFKRQQEEsFQEQSALAAEARETRRQELL |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BWD1 | T209 | Sugiyama | ACAT2 ACTL | TENAQKAGHFDKEIVPVLVstRKGLIEVKtDEFPRHGsNIE |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9C0C2 | T1323 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | ELGVGQMDWGNNLGLRDLEVtCDPDsGGsQGLRGCGVGQMD |
| Q9H444 | S87 | Sugiyama | CHMP4B C20orf178 SHAX1 | QALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLK |
| Q9H444 | T85 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALQALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEV |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9HB71 | T209 | Sugiyama | CACYBP S100A6BP SIP PNAS-107 | EGLMNVLKKIyEDGDDDMKRtINKAWVESREKQAKGDTEF_ |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NW75 | S58 | Sugiyama | GPATCH2 GPATC2 | ESSEQARGGFAEtGDHsRsIsCPLKRQARKRRGRKRRSYNV |
| Q9NW75 | T50 | Sugiyama | GPATCH2 GPATC2 | HDLVsALEESSEQARGGFAEtGDHsRsIsCPLKRQARKRRG |
| Q9NYF8 | T208 | Sugiyama | BCLAF1 BTF KIAA0164 | KDtFEHDPsEsIDEFNKssAtsGDIWPGLsAyDNsPRsPHs |
| Q9NYF8 | T304 | Sugiyama | BCLAF1 BTF KIAA0164 | ysPsQNsPIHHIPsRRsPAKtIAPQNAPRDEsRGRssFyPD |
| Q9NZZ3 | T23 | Sugiyama | CHMP5 C9orf83 SNF7DC2 CGI-34 HSPC177 PNAS-114 PNAS-2 | RLFGKAKPKAPPPsLtDCIGtVDsRAEsIDKKISRLDAELV |
| Q9P2J5 | T728 | Sugiyama | LARS1 KIAA1352 LARS | GHLLLNSEKMSKstGNFLtLtQAIDKFSADGMRLALADAGD |
| Q9UBR2 | T172 | Sugiyama | CTSZ | ETCNNYQAKDQECDKFNQCGtCNEFKECHAIRNYTLWRVGD |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9ULW6 | T342 | Sugiyama | NAP1L2 BPX | GTAIEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVT |
| Q9ULW6 | T345 | Sugiyama | NAP1L2 BPX | IEYSTGCEIDWNEGKNVtLKtIKKKQKHRIWGTIRTVTEDF |
| Q9UMX5 | T76 | Sugiyama | NENF CIR2 SPUF | GGEEEDQPIyLAVKGVVFDVtSGKEFYGRGAPYNALTGKDS |
| Q9UNF1 | T117 | Sugiyama | MAGED2 BCG1 | AENKSLAADTKKQNADPQAVtMPATEtKKVSHVADTKVNTK |
| Q9UNF1 | T123 | Sugiyama | MAGED2 BCG1 | AADTKKQNADPQAVtMPATEtKKVSHVADTKVNTKAQETEA |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNZ2 | S212 | Sugiyama | NSFL1C UBXN2C | sLDNGELRSyQDPsNAQFLEsIRRGEVPAELRRLAHGGQVN |
| Q9UQ35 | S1054 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sLCAGVKsstPPGEsyFGVssLQLKGQsQtsPDHRsDtssP |
| Q9UQ35 | T1043 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | DsLVQsCPGsLsLCAGVKsstPPGEsyFGVssLQLKGQsQt |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T60 | Sugiyama | PA2G4 EBP1 | ssGVsVLsLCEKGDAMIMEEtGKIFKKEKEMKKGIAFPTSI |
| Q9Y247 | S62 | Sugiyama | FAM50B X5L | KSQVDKRFSAHyDAVEAELKsstVGLVtLNDMKARQEALVR |
| Q9Y247 | T69 | Sugiyama | FAM50B X5L | FSAHyDAVEAELKsstVGLVtLNDMKARQEALVRERERQLA |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | T100 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | ELLEEICDRMKEyGEQIDPstHRKNYVRVVGRNGEssELDL |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2T7 | S137 | Sugiyama | YBX2 CSDA3 MSY2 | EDVFVHQtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEA |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y3F4 | T48 | Sugiyama | STRAP MAWD UNRIP | YGYFLISACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLN |
| Q9Y3F4 | T54 | Sugiyama | STRAP MAWD UNRIP | SACKDGKPMLRQGDtGDWIGtFLGHKGAVWGAtLNKDATKA |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Oncogene Induced Senescence | R-HSA-2559585 | 0.000010 | 4.999 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.000228 | 3.642 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.000166 | 3.779 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.000238 | 3.623 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.000224 | 3.650 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.000598 | 3.224 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.000598 | 3.224 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.000598 | 3.224 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.000598 | 3.224 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.000295 | 3.530 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.000538 | 3.269 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.001538 | 2.813 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.001712 | 2.766 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.002512 | 2.600 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.002512 | 2.600 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.002544 | 2.594 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 0.002795 | 2.554 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.003108 | 2.508 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.003204 | 2.494 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.004138 | 2.383 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.004138 | 2.383 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.004138 | 2.383 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.004250 | 2.372 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.004611 | 2.336 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.005392 | 2.268 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 0.005877 | 2.231 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.006648 | 2.177 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.006592 | 2.181 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.006592 | 2.181 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.006536 | 2.185 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.006569 | 2.183 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.007576 | 2.121 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.007499 | 2.125 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.007478 | 2.126 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.007483 | 2.126 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.007499 | 2.125 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.007315 | 2.136 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.008029 | 2.095 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.008002 | 2.097 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.009516 | 2.022 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 0.011427 | 1.942 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 0.011427 | 1.942 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 0.011427 | 1.942 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.011427 | 1.942 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.009906 | 2.004 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.011164 | 1.952 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.010122 | 1.995 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.011087 | 1.955 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.010522 | 1.978 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.012468 | 1.904 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.012196 | 1.914 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.012135 | 1.916 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.012968 | 1.887 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.013961 | 1.855 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.013739 | 1.862 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.013501 | 1.870 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.014010 | 1.854 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.014475 | 1.839 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.014475 | 1.839 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.015570 | 1.808 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.015570 | 1.808 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.015570 | 1.808 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.016279 | 1.788 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.017345 | 1.761 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.017097 | 1.767 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.016906 | 1.772 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.017395 | 1.760 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.018692 | 1.728 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.019593 | 1.708 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.019593 | 1.708 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.020717 | 1.684 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.024406 | 1.613 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.022856 | 1.641 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.023923 | 1.621 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.023230 | 1.634 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.023923 | 1.621 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.022582 | 1.646 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.022582 | 1.646 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.021338 | 1.671 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.023016 | 1.638 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.023650 | 1.626 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.021107 | 1.676 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.023923 | 1.621 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.026951 | 1.569 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.026951 | 1.569 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.026951 | 1.569 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.026951 | 1.569 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.026951 | 1.569 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.026951 | 1.569 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.026839 | 1.571 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 0.025465 | 1.594 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.025396 | 1.595 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.025446 | 1.594 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.029903 | 1.524 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.032369 | 1.490 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.029903 | 1.524 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.030477 | 1.516 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.030337 | 1.518 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.029903 | 1.524 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.031436 | 1.503 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 0.032369 | 1.490 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.032369 | 1.490 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.032594 | 1.487 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.032978 | 1.482 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 0.033282 | 1.478 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.034679 | 1.460 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 0.039085 | 1.408 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 0.039085 | 1.408 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 0.039085 | 1.408 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 0.039085 | 1.408 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.036776 | 1.434 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.036813 | 1.434 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.036419 | 1.439 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.036361 | 1.439 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.036689 | 1.435 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.036419 | 1.439 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.038999 | 1.409 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.041200 | 1.385 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.041200 | 1.385 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.041200 | 1.385 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.041409 | 1.383 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 0.041409 | 1.383 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 0.046938 | 1.328 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.044498 | 1.352 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.048291 | 1.316 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.048291 | 1.316 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.047166 | 1.326 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.044498 | 1.352 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.045213 | 1.345 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.044169 | 1.355 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 0.048651 | 1.313 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.049145 | 1.309 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.049801 | 1.303 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 0.050818 | 1.294 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.051781 | 1.286 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.052172 | 1.283 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.053011 | 1.276 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 0.076645 | 1.116 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 0.076645 | 1.116 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 0.076645 | 1.116 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 0.076645 | 1.116 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 0.112739 | 0.948 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 0.112739 | 0.948 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 0.112739 | 0.948 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 0.112739 | 0.948 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 0.112739 | 0.948 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 0.112739 | 0.948 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 0.112739 | 0.948 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 0.112739 | 0.948 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.061149 | 1.214 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 0.180755 | 0.743 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 0.180755 | 0.743 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 0.072123 | 1.142 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.072123 | 1.142 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.072123 | 1.142 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 0.083674 | 1.077 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 0.212786 | 0.672 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.212786 | 0.672 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 0.212786 | 0.672 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 0.095740 | 1.019 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.095740 | 1.019 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 0.095740 | 1.019 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.108263 | 0.966 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.108263 | 0.966 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.108263 | 0.966 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.108263 | 0.966 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.108263 | 0.966 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.243565 | 0.613 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.243565 | 0.613 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.243565 | 0.613 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.059017 | 1.229 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.059017 | 1.229 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.121190 | 0.917 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.121190 | 0.917 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 0.273143 | 0.564 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 0.273143 | 0.564 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.079554 | 1.099 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 0.148054 | 0.830 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.087002 | 1.060 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.087002 | 1.060 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.087002 | 1.060 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 0.087002 | 1.060 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.094733 | 1.023 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.094733 | 1.023 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 0.094733 | 1.023 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.161901 | 0.791 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.301567 | 0.521 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 0.301567 | 0.521 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.102734 | 0.988 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 0.175967 | 0.755 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.175967 | 0.755 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.175967 | 0.755 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.110992 | 0.955 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.077849 | 1.109 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.119495 | 0.923 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 0.119495 | 0.923 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.328880 | 0.483 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.328880 | 0.483 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.328880 | 0.483 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 0.328880 | 0.483 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.328880 | 0.483 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.328880 | 0.483 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 0.328880 | 0.483 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.204612 | 0.689 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.137185 | 0.863 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.146345 | 0.835 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.146345 | 0.835 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.219120 | 0.659 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 0.355127 | 0.450 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.355127 | 0.450 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 0.355127 | 0.450 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 0.355127 | 0.450 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.355127 | 0.450 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.233712 | 0.631 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.248357 | 0.605 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.380349 | 0.420 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.078526 | 1.105 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.184786 | 0.733 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.263029 | 0.580 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.263029 | 0.580 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.263029 | 0.580 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.263029 | 0.580 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.171190 | 0.767 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.171190 | 0.767 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.171190 | 0.767 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.150482 | 0.823 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.427876 | 0.369 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 0.427876 | 0.369 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.202918 | 0.693 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.350396 | 0.455 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.193961 | 0.712 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.310734 | 0.508 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.406724 | 0.391 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.314805 | 0.502 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.314805 | 0.502 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.364698 | 0.438 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.332655 | 0.478 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.341599 | 0.466 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.404133 | 0.393 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.421841 | 0.375 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.353541 | 0.452 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.235941 | 0.627 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.165231 | 0.782 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.174931 | 0.757 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.235941 | 0.627 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.092855 | 1.032 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.057576 | 1.240 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.089118 | 1.050 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.257282 | 0.590 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.170484 | 0.768 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 0.083407 | 1.079 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.359503 | 0.444 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 0.108263 | 0.966 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 0.356524 | 0.448 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.360771 | 0.443 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.260874 | 0.584 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 0.321539 | 0.493 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.095740 | 1.019 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.328880 | 0.483 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.117063 | 0.932 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.307637 | 0.512 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.075730 | 1.121 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.270580 | 0.568 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.072400 | 1.140 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.095740 | 1.019 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 0.263029 | 0.580 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.404586 | 0.393 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.292361 | 0.534 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.378828 | 0.422 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.132426 | 0.878 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.065550 | 1.183 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.306976 | 0.513 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.257060 | 0.590 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.174931 | 0.757 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.171190 | 0.767 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 0.321539 | 0.493 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.182685 | 0.738 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.246639 | 0.608 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.072123 | 1.142 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 0.134469 | 0.871 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 0.134469 | 0.871 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 0.134469 | 0.871 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.148054 | 0.830 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.161901 | 0.791 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.204612 | 0.689 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 0.380349 | 0.420 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.350396 | 0.455 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.116458 | 0.934 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.377396 | 0.423 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.275889 | 0.559 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.289165 | 0.539 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.080217 | 1.096 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.163547 | 0.786 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.128330 | 0.892 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.099539 | 1.002 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.109999 | 0.959 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 0.336011 | 0.474 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.364673 | 0.438 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.310755 | 0.508 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.055332 | 1.257 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.148651 | 0.828 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.225716 | 0.646 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.302463 | 0.519 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 0.212786 | 0.672 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.108263 | 0.966 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.243565 | 0.613 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 0.148054 | 0.830 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.328880 | 0.483 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 0.328880 | 0.483 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 0.355127 | 0.450 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.233712 | 0.631 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.115421 | 0.938 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 0.427876 | 0.369 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.392848 | 0.406 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.163063 | 0.788 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.179707 | 0.745 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.179707 | 0.745 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.179707 | 0.745 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.148054 | 0.830 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.246465 | 0.608 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.321532 | 0.493 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.098825 | 1.005 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.138332 | 0.859 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.138332 | 0.859 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.138332 | 0.859 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.138332 | 0.859 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.188211 | 0.725 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.212786 | 0.672 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.212786 | 0.672 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 0.243565 | 0.613 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.273143 | 0.564 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 0.175967 | 0.755 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.277705 | 0.556 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.169507 | 0.771 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.217155 | 0.663 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 0.233712 | 0.631 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.215151 | 0.667 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.420444 | 0.376 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 0.083674 | 1.077 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.204612 | 0.689 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.248357 | 0.605 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.364673 | 0.438 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.406724 | 0.391 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.072484 | 1.140 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.092966 | 1.032 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 0.076645 | 1.116 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 0.112739 | 0.948 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 0.112739 | 0.948 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 0.147424 | 0.831 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 0.147424 | 0.831 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.083674 | 1.077 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 0.108263 | 0.966 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 0.108263 | 0.966 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.108263 | 0.966 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 0.243565 | 0.613 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 0.121190 | 0.917 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.121190 | 0.917 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.121190 | 0.917 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.065550 | 1.183 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 0.273143 | 0.564 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 0.301567 | 0.521 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 0.328880 | 0.483 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 0.233712 | 0.631 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.184786 | 0.733 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.194782 | 0.710 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 0.404586 | 0.393 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.404586 | 0.393 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.404586 | 0.393 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 0.404586 | 0.393 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 0.404586 | 0.393 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.106525 | 0.973 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.156032 | 0.807 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.235941 | 0.627 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.132566 | 0.878 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.387520 | 0.412 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.182685 | 0.738 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.336011 | 0.474 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.297646 | 0.526 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.321539 | 0.493 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.105003 | 0.979 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.291144 | 0.536 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.311373 | 0.507 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.095740 | 1.019 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.243565 | 0.613 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 0.355127 | 0.450 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.057231 | 1.242 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.289165 | 0.539 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.289165 | 0.539 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.406724 | 0.391 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.306405 | 0.514 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.053792 | 1.269 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.138332 | 0.859 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.106047 | 0.975 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 0.212786 | 0.672 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.328880 | 0.483 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.328880 | 0.483 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 0.075730 | 1.121 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 0.380349 | 0.420 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 0.380349 | 0.420 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.289165 | 0.539 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.378828 | 0.422 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.364698 | 0.438 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.292361 | 0.534 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.323302 | 0.490 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 0.155698 | 0.808 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.306976 | 0.513 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.156721 | 0.805 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.170484 | 0.768 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.350396 | 0.455 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.339233 | 0.470 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.063893 | 1.195 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.094603 | 1.024 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.067388 | 1.171 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.067388 | 1.171 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.204908 | 0.688 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.392848 | 0.406 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.406724 | 0.391 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.087002 | 1.060 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.134312 | 0.872 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.150461 | 0.823 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.057418 | 1.241 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.424074 | 0.373 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.424074 | 0.373 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.094758 | 1.023 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.112739 | 0.948 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 0.180755 | 0.743 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 0.212786 | 0.672 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 0.243565 | 0.613 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.273143 | 0.564 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 0.190216 | 0.721 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 0.328880 | 0.483 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 0.328880 | 0.483 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.233712 | 0.631 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.380349 | 0.420 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 0.427876 | 0.369 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.427876 | 0.369 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.227758 | 0.643 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.176239 | 0.754 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.224282 | 0.649 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.231477 | 0.635 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.097140 | 1.013 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.392848 | 0.406 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 0.353934 | 0.451 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.339462 | 0.469 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.072600 | 1.139 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.386326 | 0.413 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.205068 | 0.688 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.094733 | 1.023 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.144352 | 0.841 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 0.175967 | 0.755 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.058965 | 1.229 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.278421 | 0.555 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.132767 | 0.877 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.396783 | 0.401 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.123423 | 0.909 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.323722 | 0.490 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.178855 | 0.747 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.057305 | 1.242 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.142958 | 0.845 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.129622 | 0.887 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 0.180755 | 0.743 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.094733 | 1.023 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.301567 | 0.521 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.248357 | 0.605 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 0.380349 | 0.420 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.204908 | 0.688 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.111035 | 0.955 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.137185 | 0.863 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.059017 | 1.229 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.175967 | 0.755 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.162274 | 0.790 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.141409 | 0.850 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.156824 | 0.805 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.187979 | 0.726 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.370216 | 0.432 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 0.061149 | 1.214 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 0.212786 | 0.672 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 0.095740 | 1.019 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.243565 | 0.613 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 0.243565 | 0.613 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 0.273143 | 0.564 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.148054 | 0.830 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.094733 | 1.023 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.301567 | 0.521 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.062345 | 1.205 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 0.328880 | 0.483 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 0.328880 | 0.483 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 0.328880 | 0.483 | 0 | 0 |
| PKA activation | R-HSA-163615 | 0.233712 | 0.631 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.380349 | 0.420 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.380349 | 0.420 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 0.427876 | 0.369 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.278421 | 0.555 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.297044 | 0.527 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.420444 | 0.376 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.189412 | 0.723 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.073742 | 1.132 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.212999 | 0.672 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.073742 | 1.132 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.073742 | 1.132 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.253310 | 0.596 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.261958 | 0.582 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.179304 | 0.746 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.375432 | 0.425 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.062374 | 1.205 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 0.404586 | 0.393 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 0.404586 | 0.393 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.377396 | 0.423 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.114858 | 0.940 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.139238 | 0.856 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.337377 | 0.472 | 1 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.332148 | 0.479 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 0.065550 | 1.183 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.148054 | 0.830 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.380349 | 0.420 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.290827 | 0.536 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.206356 | 0.685 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.193961 | 0.712 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.386326 | 0.413 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 0.289165 | 0.539 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 0.289165 | 0.539 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.305911 | 0.514 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.062374 | 1.205 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 0.108263 | 0.966 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.072400 | 1.140 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 0.128230 | 0.892 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.275889 | 0.559 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.200825 | 0.697 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.364698 | 0.438 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.330828 | 0.480 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 0.061149 | 1.214 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 0.083674 | 1.077 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.273143 | 0.564 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.273143 | 0.564 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.087002 | 1.060 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.175967 | 0.755 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.110992 | 0.955 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 0.328880 | 0.483 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 0.204612 | 0.689 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 0.380349 | 0.420 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.094886 | 1.023 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.204908 | 0.688 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.306976 | 0.513 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 0.427876 | 0.369 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 0.427876 | 0.369 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.130842 | 0.883 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.404133 | 0.393 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.143541 | 0.843 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.360088 | 0.444 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.240682 | 0.619 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.344297 | 0.463 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.360088 | 0.444 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.086283 | 1.064 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.325201 | 0.488 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 0.215151 | 0.667 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 0.350396 | 0.455 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.406724 | 0.391 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.200825 | 0.697 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.094733 | 1.023 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.233712 | 0.631 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.263029 | 0.580 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.336011 | 0.474 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.336011 | 0.474 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.416371 | 0.381 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.076767 | 1.115 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.246465 | 0.608 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.273143 | 0.564 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.190216 | 0.721 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 0.380349 | 0.420 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 0.263029 | 0.580 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 0.404586 | 0.393 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.156721 | 0.805 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.246465 | 0.608 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.269275 | 0.570 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.279274 | 0.554 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.186835 | 0.729 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.108263 | 0.966 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.146569 | 0.834 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.275889 | 0.559 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.328182 | 0.484 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.070961 | 1.149 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 0.273143 | 0.564 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 0.161901 | 0.791 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.137185 | 0.863 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.248357 | 0.605 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 0.277705 | 0.556 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.427876 | 0.369 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.253310 | 0.596 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.364673 | 0.438 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.353934 | 0.451 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.276671 | 0.558 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.321532 | 0.493 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 0.380349 | 0.420 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.139119 | 0.857 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.343147 | 0.465 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.110294 | 0.957 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.110992 | 0.955 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.072484 | 1.140 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 0.427876 | 0.369 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 0.427876 | 0.369 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.378828 | 0.422 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.219391 | 0.659 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.378389 | 0.422 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 0.233712 | 0.631 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.404586 | 0.393 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.378828 | 0.422 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.253310 | 0.596 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 0.355127 | 0.450 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.380349 | 0.420 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.233712 | 0.631 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.204908 | 0.688 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.225499 | 0.647 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.364673 | 0.438 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.057576 | 1.240 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.404133 | 0.393 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.379926 | 0.420 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.332655 | 0.478 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.364698 | 0.438 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.278421 | 0.555 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.286204 | 0.543 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.430649 | 0.366 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 0.434001 | 0.363 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.438834 | 0.358 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.442913 | 0.354 | 0 | 0 |
| Immune System | R-HSA-168256 | 0.447967 | 0.349 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.450257 | 0.347 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 0.450257 | 0.347 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.450257 | 0.347 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 0.450257 | 0.347 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 0.450257 | 0.347 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.450257 | 0.347 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.450257 | 0.347 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.450257 | 0.347 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.450257 | 0.347 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.451072 | 0.346 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.453959 | 0.343 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.459443 | 0.338 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.460588 | 0.337 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.460588 | 0.337 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.460588 | 0.337 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.460588 | 0.337 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.460588 | 0.337 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.460588 | 0.337 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.460588 | 0.337 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.460588 | 0.337 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.460984 | 0.336 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.461598 | 0.336 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.469625 | 0.328 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.469625 | 0.328 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.469625 | 0.328 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 0.471763 | 0.326 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.471763 | 0.326 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.471763 | 0.326 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.471763 | 0.326 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.471763 | 0.326 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.471763 | 0.326 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.471763 | 0.326 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 0.471763 | 0.326 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.471763 | 0.326 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.471763 | 0.326 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.471763 | 0.326 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.471765 | 0.326 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.473606 | 0.325 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.473606 | 0.325 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 0.473606 | 0.325 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.473606 | 0.325 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.474075 | 0.324 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.479721 | 0.319 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.479721 | 0.319 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.479721 | 0.319 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.480961 | 0.318 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.485440 | 0.314 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.485440 | 0.314 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.485440 | 0.314 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.486245 | 0.313 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.486432 | 0.313 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.486432 | 0.313 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.486432 | 0.313 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.486432 | 0.313 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 0.486432 | 0.313 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.489725 | 0.310 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.492430 | 0.308 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 0.492430 | 0.308 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.492430 | 0.308 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.492430 | 0.308 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 0.492430 | 0.308 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.492430 | 0.308 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.492430 | 0.308 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 0.492430 | 0.308 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 0.492430 | 0.308 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.492430 | 0.308 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.498467 | 0.302 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.499061 | 0.302 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.504942 | 0.297 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.505737 | 0.296 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.506963 | 0.295 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.509114 | 0.293 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 0.509445 | 0.293 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.511489 | 0.291 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.511489 | 0.291 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.511489 | 0.291 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.511489 | 0.291 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 0.512289 | 0.290 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.512289 | 0.290 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.512289 | 0.290 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.512289 | 0.290 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 0.512289 | 0.290 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 0.512289 | 0.290 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 0.512289 | 0.290 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.512289 | 0.290 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 0.512289 | 0.290 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.512289 | 0.290 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.517289 | 0.286 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 0.519154 | 0.285 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.523713 | 0.281 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.523713 | 0.281 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.523713 | 0.281 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.525651 | 0.279 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.525739 | 0.279 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.529525 | 0.276 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.531372 | 0.275 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 0.531372 | 0.275 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 0.531372 | 0.275 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.531372 | 0.275 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.531372 | 0.275 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 0.531372 | 0.275 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 0.531372 | 0.275 | 0 | 0 |
| Synthesis of 12-eicosatetraenoic acid derivatives | R-HSA-2142712 | 0.531372 | 0.275 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.531372 | 0.275 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.531372 | 0.275 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.532600 | 0.274 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.535598 | 0.271 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.535730 | 0.271 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.535730 | 0.271 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.535730 | 0.271 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.547536 | 0.262 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.547536 | 0.262 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.547641 | 0.262 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.547649 | 0.261 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.549710 | 0.260 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 0.549710 | 0.260 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 0.549710 | 0.260 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 0.549710 | 0.260 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 0.549710 | 0.260 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 0.549710 | 0.260 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.549710 | 0.260 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.549710 | 0.260 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 0.549710 | 0.260 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.549710 | 0.260 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 0.549710 | 0.260 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.549710 | 0.260 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.549710 | 0.260 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.556638 | 0.254 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.556914 | 0.254 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.559130 | 0.252 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.559130 | 0.252 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.559130 | 0.252 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.564307 | 0.248 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 0.567144 | 0.246 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.567331 | 0.246 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.567331 | 0.246 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 0.567331 | 0.246 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 0.567331 | 0.246 | 0 | 0 |
| Vitamin B6 activation to pyridoxal phosphate | R-HSA-964975 | 0.567331 | 0.246 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.567331 | 0.246 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 0.567331 | 0.246 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 0.567331 | 0.246 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 0.567331 | 0.246 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.570511 | 0.244 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.570511 | 0.244 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.570511 | 0.244 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.570511 | 0.244 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.571053 | 0.243 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.575114 | 0.240 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.575114 | 0.240 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.577353 | 0.239 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 0.579372 | 0.237 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.581678 | 0.235 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.581678 | 0.235 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.581678 | 0.235 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.583607 | 0.234 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.584037 | 0.234 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 0.584263 | 0.233 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.584263 | 0.233 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 0.584263 | 0.233 | 0 | 0 |
| Synthesis of 15-eicosatetraenoic acid derivatives | R-HSA-2142770 | 0.584263 | 0.233 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.584263 | 0.233 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.584263 | 0.233 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.584263 | 0.233 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.587787 | 0.231 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.588252 | 0.230 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.592629 | 0.227 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 0.592629 | 0.227 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.593570 | 0.227 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.595277 | 0.225 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.600534 | 0.221 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.600534 | 0.221 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 0.600534 | 0.221 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.600534 | 0.221 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.600534 | 0.221 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 0.600534 | 0.221 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 0.600534 | 0.221 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 0.600534 | 0.221 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 0.600534 | 0.221 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.600534 | 0.221 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.601521 | 0.221 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.603365 | 0.219 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.603365 | 0.219 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.603365 | 0.219 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.605181 | 0.218 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.610080 | 0.215 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.610080 | 0.215 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.613885 | 0.212 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.613885 | 0.212 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.613885 | 0.212 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 0.616169 | 0.210 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.616169 | 0.210 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.616169 | 0.210 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.616169 | 0.210 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 0.616169 | 0.210 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 0.616169 | 0.210 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.616169 | 0.210 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 0.618308 | 0.209 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.624191 | 0.205 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 0.624191 | 0.205 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.631194 | 0.200 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 0.631194 | 0.200 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 0.631194 | 0.200 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 0.631194 | 0.200 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 0.631194 | 0.200 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.631194 | 0.200 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 0.631194 | 0.200 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.631194 | 0.200 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.631194 | 0.200 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 0.631194 | 0.200 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 0.631194 | 0.200 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.631807 | 0.199 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.633279 | 0.198 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.634282 | 0.198 | 1 | 1 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.635010 | 0.197 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.638854 | 0.195 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.638854 | 0.195 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.643069 | 0.192 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.643069 | 0.192 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.644161 | 0.191 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.644161 | 0.191 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 0.645630 | 0.190 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 0.645630 | 0.190 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 0.645630 | 0.190 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.645630 | 0.190 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.645630 | 0.190 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.645630 | 0.190 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 0.645630 | 0.190 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 0.645630 | 0.190 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 0.645630 | 0.190 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.646734 | 0.189 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.651002 | 0.186 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.653827 | 0.185 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.658809 | 0.181 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.659503 | 0.181 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.659503 | 0.181 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 0.659503 | 0.181 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.659503 | 0.181 | 0 | 0 |
| Eicosanoids | R-HSA-211979 | 0.659503 | 0.181 | 0 | 0 |
| Miscellaneous substrates | R-HSA-211958 | 0.659503 | 0.181 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 0.659503 | 0.181 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.659503 | 0.181 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.663282 | 0.178 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.663282 | 0.178 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.664600 | 0.177 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.665812 | 0.177 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.672529 | 0.172 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.672833 | 0.172 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 0.672833 | 0.172 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.672833 | 0.172 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.672833 | 0.172 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.672833 | 0.172 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.672833 | 0.172 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.672833 | 0.172 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 0.672833 | 0.172 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.674230 | 0.171 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.676681 | 0.170 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.681569 | 0.166 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.681569 | 0.166 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.681569 | 0.166 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.685643 | 0.164 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.685643 | 0.164 | 0 | 0 |
| Fatty acids | R-HSA-211935 | 0.685643 | 0.164 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.685643 | 0.164 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 0.685643 | 0.164 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.685643 | 0.164 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.685643 | 0.164 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.688140 | 0.162 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.688768 | 0.162 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.690403 | 0.161 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.690403 | 0.161 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.697951 | 0.156 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.697951 | 0.156 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 0.697951 | 0.156 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 0.697951 | 0.156 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.699035 | 0.156 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.703189 | 0.153 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.704385 | 0.152 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.709778 | 0.149 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 0.709778 | 0.149 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 0.709778 | 0.149 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 0.709778 | 0.149 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 0.709778 | 0.149 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.709778 | 0.149 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.709778 | 0.149 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.709778 | 0.149 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.709778 | 0.149 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.714180 | 0.146 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.715700 | 0.145 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.721143 | 0.142 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.721143 | 0.142 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.721143 | 0.142 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.721143 | 0.142 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 0.721143 | 0.142 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.721143 | 0.142 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 0.721143 | 0.142 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.731583 | 0.136 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.732064 | 0.135 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.732064 | 0.135 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.732064 | 0.135 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 0.732064 | 0.135 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.732064 | 0.135 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 0.732064 | 0.135 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.737317 | 0.132 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.739238 | 0.131 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.742557 | 0.129 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.742557 | 0.129 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.742557 | 0.129 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.744736 | 0.128 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.746706 | 0.127 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.748858 | 0.126 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.752640 | 0.123 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.752640 | 0.123 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.752640 | 0.123 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.752640 | 0.123 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 0.752640 | 0.123 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.755619 | 0.122 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.755619 | 0.122 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.760874 | 0.119 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.761092 | 0.119 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.761092 | 0.119 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.762329 | 0.118 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.762329 | 0.118 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 0.762329 | 0.118 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.762329 | 0.118 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.762329 | 0.118 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.763864 | 0.117 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.766024 | 0.116 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.768016 | 0.115 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.768016 | 0.115 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.768016 | 0.115 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.771639 | 0.113 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.771639 | 0.113 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.771639 | 0.113 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 0.771639 | 0.113 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.771639 | 0.113 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.772419 | 0.112 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.774765 | 0.111 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.778019 | 0.109 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.780584 | 0.108 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 0.780584 | 0.108 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.780584 | 0.108 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.781178 | 0.107 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.781341 | 0.107 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.782022 | 0.107 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.785791 | 0.105 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.788727 | 0.103 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.788879 | 0.103 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.789180 | 0.103 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 0.789180 | 0.103 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 0.789180 | 0.103 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.789180 | 0.103 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 0.789180 | 0.103 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.794920 | 0.100 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.795165 | 0.100 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.797440 | 0.098 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.797440 | 0.098 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.797440 | 0.098 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.799294 | 0.097 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.799726 | 0.097 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.800070 | 0.097 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.804621 | 0.094 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.805376 | 0.094 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.805376 | 0.094 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.805376 | 0.094 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.805376 | 0.094 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.805376 | 0.094 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.805376 | 0.094 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.805376 | 0.094 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 0.805376 | 0.094 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.805376 | 0.094 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 0.805376 | 0.094 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.805376 | 0.094 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.805376 | 0.094 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.808603 | 0.092 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.809276 | 0.092 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.810454 | 0.091 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.813002 | 0.090 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.813002 | 0.090 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.813002 | 0.090 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 0.813002 | 0.090 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.815078 | 0.089 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.817363 | 0.088 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.817363 | 0.088 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.820330 | 0.086 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.820330 | 0.086 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.820330 | 0.086 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.820330 | 0.086 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.820330 | 0.086 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.820330 | 0.086 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.822823 | 0.085 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 0.827371 | 0.082 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.827371 | 0.082 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 0.827371 | 0.082 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.827371 | 0.082 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.828136 | 0.082 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 0.828136 | 0.082 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.828139 | 0.082 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.830037 | 0.081 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.834136 | 0.079 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.834136 | 0.079 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.834136 | 0.079 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 0.834136 | 0.079 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 0.834136 | 0.079 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.834136 | 0.079 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.836172 | 0.078 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.836736 | 0.077 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.838333 | 0.077 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.838333 | 0.077 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.840637 | 0.075 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.840637 | 0.075 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 0.840637 | 0.075 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.840949 | 0.075 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.843224 | 0.074 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.843224 | 0.074 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.846883 | 0.072 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.846883 | 0.072 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.846883 | 0.072 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.846883 | 0.072 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.847980 | 0.072 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 0.851826 | 0.070 | 1 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.852605 | 0.069 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.852885 | 0.069 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.852885 | 0.069 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.852885 | 0.069 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.857101 | 0.067 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.857101 | 0.067 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.857466 | 0.067 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.858652 | 0.066 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.858652 | 0.066 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.860721 | 0.065 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.864193 | 0.063 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.864193 | 0.063 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.864193 | 0.063 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.864403 | 0.063 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.869517 | 0.061 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.869746 | 0.061 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.871512 | 0.060 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.873859 | 0.059 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.874633 | 0.058 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 0.874633 | 0.058 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.874633 | 0.058 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.874800 | 0.058 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.874942 | 0.058 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.876670 | 0.057 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.876670 | 0.057 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.879042 | 0.056 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.879548 | 0.056 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.879548 | 0.056 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.879548 | 0.056 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.879548 | 0.056 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.879597 | 0.056 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.880301 | 0.055 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.880301 | 0.055 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.881312 | 0.055 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.881542 | 0.055 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.881559 | 0.055 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 0.884272 | 0.053 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 0.884272 | 0.053 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.884749 | 0.053 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.885219 | 0.053 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.885594 | 0.053 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.886637 | 0.052 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.887862 | 0.052 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.888790 | 0.051 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 0.888810 | 0.051 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.888810 | 0.051 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.888810 | 0.051 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 0.888810 | 0.051 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 0.893170 | 0.049 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.893170 | 0.049 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 0.893170 | 0.049 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.893864 | 0.049 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.897232 | 0.047 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.897360 | 0.047 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.897360 | 0.047 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.897360 | 0.047 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 0.898604 | 0.046 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.899576 | 0.046 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.901386 | 0.045 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.905149 | 0.043 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.905149 | 0.043 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.908970 | 0.041 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.908970 | 0.041 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.908970 | 0.041 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.911041 | 0.040 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.911176 | 0.040 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.912541 | 0.040 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.912541 | 0.040 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.912541 | 0.040 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.912541 | 0.040 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.913856 | 0.039 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.914798 | 0.039 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.919269 | 0.037 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.919754 | 0.036 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.920242 | 0.036 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.921997 | 0.035 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.922269 | 0.035 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.922436 | 0.035 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.922436 | 0.035 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.922436 | 0.035 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.924249 | 0.034 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.924303 | 0.034 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 0.925480 | 0.034 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.926722 | 0.033 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.928404 | 0.032 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.928404 | 0.032 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.930038 | 0.031 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.931214 | 0.031 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.931214 | 0.031 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.931214 | 0.031 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.931214 | 0.031 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.931214 | 0.031 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.933913 | 0.030 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.933913 | 0.030 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.934297 | 0.030 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 0.935007 | 0.029 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.935686 | 0.029 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.936164 | 0.029 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.936507 | 0.028 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.936507 | 0.028 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.936507 | 0.028 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.936507 | 0.028 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 0.937340 | 0.028 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.938999 | 0.027 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.939768 | 0.027 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.943604 | 0.025 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.945434 | 0.024 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.947207 | 0.024 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.947582 | 0.023 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.947582 | 0.023 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 0.948028 | 0.023 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.950590 | 0.022 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.950590 | 0.022 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.953571 | 0.021 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 0.954422 | 0.020 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.955723 | 0.020 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.955723 | 0.020 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.956606 | 0.019 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.957462 | 0.019 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.957462 | 0.019 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.957462 | 0.019 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.958166 | 0.019 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.958166 | 0.019 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.958166 | 0.019 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.958255 | 0.019 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 0.959132 | 0.018 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.959132 | 0.018 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.960734 | 0.017 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.960738 | 0.017 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.960738 | 0.017 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 0.962280 | 0.017 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.962280 | 0.017 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.963761 | 0.016 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 0.965640 | 0.015 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 0.965992 | 0.015 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.966659 | 0.015 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.967867 | 0.014 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.967867 | 0.014 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.967867 | 0.014 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.968613 | 0.014 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 0.969129 | 0.014 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.970342 | 0.013 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.970638 | 0.013 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.971111 | 0.013 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.971111 | 0.013 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.971508 | 0.013 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.972087 | 0.012 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.972627 | 0.012 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.973703 | 0.012 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.973703 | 0.012 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.974737 | 0.011 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 0.974737 | 0.011 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 0.975237 | 0.011 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.977600 | 0.010 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.978741 | 0.009 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.979327 | 0.009 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 0.979327 | 0.009 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 0.980821 | 0.008 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.980921 | 0.008 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.981671 | 0.008 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.983084 | 0.007 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 0.983749 | 0.007 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.983749 | 0.007 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.984389 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.984389 | 0.007 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 0.984716 | 0.007 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.985003 | 0.007 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.985017 | 0.007 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.985480 | 0.006 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.985593 | 0.006 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.985593 | 0.006 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.986471 | 0.006 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.986704 | 0.006 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.986704 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.986744 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.987730 | 0.005 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 0.988356 | 0.005 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 0.988590 | 0.005 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.988676 | 0.005 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.988885 | 0.005 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.989550 | 0.005 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.990356 | 0.004 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.990356 | 0.004 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 0.990749 | 0.004 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.991101 | 0.004 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.991375 | 0.004 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.991451 | 0.004 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 0.991739 | 0.004 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.991788 | 0.004 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.991788 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.992422 | 0.003 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 0.992720 | 0.003 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 0.993399 | 0.003 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.994415 | 0.002 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.994505 | 0.002 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.994505 | 0.002 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.994647 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.994722 | 0.002 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.995595 | 0.002 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 0.995853 | 0.002 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 0.996173 | 0.002 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 0.997965 | 0.001 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.997990 | 0.001 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.998356 | 0.001 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 0.998543 | 0.001 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 0.999055 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.999102 | 0.000 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.999102 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.999233 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 0.999248 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.999323 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 0.999400 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.999400 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 0.999428 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.999710 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 0.999823 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 0.999829 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 0.999919 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 0.999954 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 0.999960 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 0.999968 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 0.999970 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.999978 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 0.999997 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 0.999998 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 0.999998 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | 0.000 | 1 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| DNA methylation | R-HSA-5334118 | 1.110223e-16 | 15.955 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.110223e-16 | 15.955 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.110223e-16 | 15.955 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 1.110223e-16 | 15.955 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.110223e-16 | 15.955 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.110223e-16 | 15.955 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.110223e-16 | 15.955 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.110223e-16 | 15.955 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.220446e-16 | 15.654 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.220446e-16 | 15.654 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.330669e-16 | 15.477 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.330669e-16 | 15.477 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.771561e-16 | 15.109 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.881784e-16 | 15.051 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.332268e-15 | 14.875 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.665335e-15 | 14.778 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.887379e-15 | 14.724 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.109424e-15 | 14.676 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.442491e-15 | 14.612 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.774758e-15 | 14.423 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.550316e-15 | 14.184 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.549517e-15 | 14.122 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.032507e-14 | 13.986 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.065814e-14 | 13.972 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.153833e-14 | 13.667 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.231548e-14 | 13.651 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.019807e-14 | 13.520 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.586020e-14 | 13.445 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.862777e-14 | 13.313 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.862777e-14 | 13.313 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.438494e-14 | 13.129 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 8.426593e-14 | 13.074 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.958701e-14 | 13.002 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.227907e-13 | 12.911 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.253442e-13 | 12.902 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.513234e-13 | 12.820 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.513234e-13 | 12.820 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.687539e-13 | 12.773 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.687539e-13 | 12.773 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.959544e-13 | 12.708 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.977307e-13 | 12.704 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.354783e-13 | 12.628 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.016476e-13 | 12.521 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.022027e-13 | 12.520 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.289591e-13 | 12.483 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.042944e-13 | 12.219 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 8.582024e-13 | 12.066 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.915402e-13 | 12.004 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.078138e-12 | 11.967 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.331379e-12 | 11.876 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.406653e-12 | 11.852 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.855516e-12 | 11.732 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.950662e-12 | 11.710 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.293832e-12 | 11.639 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.416845e-12 | 11.617 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.783107e-12 | 11.555 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 3.473777e-12 | 11.459 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 3.473777e-12 | 11.459 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.680611e-12 | 11.434 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 4.013123e-12 | 11.397 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.895861e-12 | 11.310 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.642598e-12 | 11.249 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.174483e-12 | 11.144 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.174483e-12 | 11.144 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.305601e-12 | 11.136 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.623102e-12 | 11.064 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.619649e-11 | 10.791 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.052103e-11 | 10.688 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.666423e-11 | 10.574 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.084810e-11 | 10.511 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.218881e-11 | 10.375 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 4.576961e-11 | 10.339 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 4.466649e-11 | 10.350 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.734024e-11 | 10.325 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.317435e-11 | 10.274 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.538881e-11 | 10.123 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 7.557732e-11 | 10.122 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 8.508916e-11 | 10.070 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.023944e-10 | 9.990 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.167482e-10 | 9.933 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.297579e-10 | 9.887 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.391305e-10 | 9.857 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.391305e-10 | 9.857 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.630016e-10 | 9.788 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.885482e-10 | 9.725 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.626399e-10 | 9.581 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.914522e-10 | 9.535 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.944363e-10 | 9.531 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.895101e-10 | 9.409 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.239988e-10 | 9.373 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.239988e-10 | 9.373 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.675390e-10 | 9.330 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 5.227733e-10 | 9.282 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.557891e-10 | 9.183 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.744960e-10 | 9.171 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.936795e-10 | 9.003 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.119792e-09 | 8.951 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.282416e-09 | 8.892 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.443628e-09 | 8.841 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 1.503302e-09 | 8.823 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.849479e-09 | 8.733 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.036353e-09 | 8.691 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.678697e-09 | 8.572 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.681023e-09 | 8.572 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.992435e-09 | 8.524 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.172663e-09 | 8.499 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.338046e-09 | 8.477 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.516789e-09 | 8.454 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.568972e-09 | 8.447 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.778851e-09 | 8.423 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.820628e-09 | 8.418 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 5.236787e-09 | 8.281 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.368993e-09 | 8.196 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 6.368993e-09 | 8.196 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.399080e-09 | 8.131 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.399080e-09 | 8.131 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 7.985126e-09 | 8.098 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.128205e-09 | 8.090 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.053577e-08 | 7.977 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.113554e-08 | 7.953 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.207674e-08 | 7.918 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.368829e-08 | 7.864 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.376317e-08 | 7.861 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.586728e-08 | 7.799 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.586728e-08 | 7.799 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.838898e-08 | 7.735 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.860294e-08 | 7.730 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.208601e-08 | 7.656 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.258807e-08 | 7.646 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 2.459080e-08 | 7.609 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.565520e-08 | 7.591 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.057350e-08 | 7.515 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 3.135246e-08 | 7.504 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.477764e-08 | 7.459 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.719478e-08 | 7.430 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.387225e-08 | 7.358 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.880014e-08 | 7.312 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.068666e-08 | 7.295 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.308486e-08 | 7.200 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.943077e-08 | 7.158 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.904684e-08 | 7.102 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.231417e-08 | 7.141 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.012020e-08 | 7.096 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.255226e-08 | 7.083 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.534554e-08 | 7.021 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.012382e-07 | 6.995 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.063177e-07 | 6.973 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.366938e-07 | 6.864 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 1.484740e-07 | 6.828 | 0 | 0 |
| Translation | R-HSA-72766 | 1.743147e-07 | 6.759 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.761025e-07 | 6.754 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.910791e-07 | 6.719 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.918211e-07 | 6.717 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.967754e-07 | 6.706 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.021671e-07 | 6.694 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.455792e-07 | 6.610 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.455792e-07 | 6.610 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.484390e-07 | 6.605 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.484390e-07 | 6.605 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.484390e-07 | 6.605 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.493024e-07 | 6.603 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.151530e-07 | 6.382 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.356569e-07 | 6.361 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 5.491346e-07 | 6.260 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.491346e-07 | 6.260 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.544216e-07 | 6.256 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.565031e-07 | 6.255 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 5.619096e-07 | 6.250 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.814303e-07 | 6.236 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 5.926960e-07 | 6.227 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.036014e-07 | 6.219 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.146347e-07 | 6.211 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.286878e-07 | 6.202 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.592968e-07 | 6.120 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 7.911083e-07 | 6.102 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 7.911083e-07 | 6.102 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 7.911083e-07 | 6.102 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 7.911083e-07 | 6.102 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.551910e-07 | 6.020 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.000670e-06 | 6.000 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.081207e-06 | 5.966 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.102269e-06 | 5.958 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.057509e-06 | 5.687 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.960907e-06 | 5.708 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.951849e-06 | 5.710 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.964721e-06 | 5.707 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.301993e-06 | 5.638 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.347305e-06 | 5.629 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.763333e-06 | 5.559 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.043305e-06 | 5.517 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 3.093057e-06 | 5.510 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 3.254028e-06 | 5.488 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.254028e-06 | 5.488 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.474782e-06 | 5.459 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 3.598863e-06 | 5.444 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.967221e-06 | 5.402 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.027105e-06 | 5.395 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.605898e-06 | 5.337 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 5.043590e-06 | 5.297 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.356024e-06 | 5.271 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.010840e-06 | 5.221 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.671137e-06 | 5.176 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.671137e-06 | 5.176 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.073002e-06 | 5.093 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.171568e-06 | 5.088 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 8.685013e-06 | 5.061 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.706100e-06 | 5.060 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.063176e-06 | 5.043 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.527246e-06 | 5.021 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.964180e-06 | 5.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.182866e-05 | 4.927 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.214139e-05 | 4.916 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.343956e-05 | 4.872 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.350350e-05 | 4.870 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.632285e-05 | 4.787 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.818807e-05 | 4.740 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.057675e-05 | 4.687 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.783512e-05 | 4.555 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.592150e-05 | 4.586 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.509685e-05 | 4.600 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.835292e-05 | 4.547 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.560898e-05 | 4.448 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.617886e-05 | 4.442 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 3.659467e-05 | 4.437 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.105975e-05 | 4.387 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.430103e-05 | 4.265 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.984299e-05 | 4.156 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.187265e-05 | 4.143 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.844886e-05 | 4.105 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.082303e-05 | 4.092 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.038907e-04 | 3.983 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.069006e-04 | 3.971 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 1.143659e-04 | 3.942 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 1.216547e-04 | 3.915 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.243528e-04 | 3.905 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.377068e-04 | 3.861 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.428510e-04 | 3.845 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.522446e-04 | 3.817 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.628875e-04 | 3.788 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.747323e-04 | 3.758 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.984144e-04 | 3.702 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.984144e-04 | 3.702 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.141672e-04 | 3.669 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.193102e-04 | 3.659 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.330575e-04 | 3.633 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.576929e-04 | 3.589 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.606358e-04 | 3.584 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 2.704629e-04 | 3.568 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.763429e-04 | 3.559 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.945902e-04 | 3.531 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.106792e-04 | 3.508 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.500289e-04 | 3.456 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.694098e-04 | 3.432 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.964465e-04 | 3.402 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 4.865359e-04 | 3.313 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 4.887782e-04 | 3.311 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.044079e-04 | 3.297 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.099022e-04 | 3.293 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.445507e-04 | 3.264 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.571798e-04 | 3.254 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 6.492162e-04 | 3.188 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.946446e-04 | 3.100 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.492162e-04 | 3.188 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.861130e-04 | 3.164 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 6.624085e-04 | 3.179 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.011314e-04 | 3.096 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.231209e-04 | 3.085 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.955430e-04 | 3.048 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.000591e-04 | 3.046 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.082422e-04 | 3.042 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 1.010987e-03 | 2.995 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.103518e-03 | 2.957 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.239633e-03 | 2.907 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.288825e-03 | 2.890 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.336679e-03 | 2.874 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.597134e-03 | 2.797 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.729847e-03 | 2.762 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 1.898413e-03 | 2.722 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.989175e-03 | 2.701 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.989175e-03 | 2.701 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.989175e-03 | 2.701 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.276858e-03 | 2.643 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 2.283826e-03 | 2.641 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.303759e-03 | 2.638 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.385444e-03 | 2.622 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.728735e-03 | 2.564 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.842505e-03 | 2.546 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.844913e-03 | 2.546 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.023827e-03 | 2.519 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.052256e-03 | 2.515 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.486565e-03 | 2.458 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.749682e-03 | 2.426 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 3.749682e-03 | 2.426 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 4.164006e-03 | 2.380 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.208258e-03 | 2.376 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 4.234293e-03 | 2.373 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.279206e-03 | 2.369 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.279206e-03 | 2.369 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.706981e-03 | 2.327 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.246649e-03 | 2.280 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.246649e-03 | 2.280 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.444423e-03 | 2.264 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.566528e-03 | 2.254 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.593168e-03 | 2.252 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.659480e-03 | 2.247 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.206693e-03 | 2.207 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.869814e-03 | 2.163 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 9.112787e-03 | 2.040 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 9.112787e-03 | 2.040 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 9.112787e-03 | 2.040 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 9.112787e-03 | 2.040 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 9.112787e-03 | 2.040 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.340042e-03 | 2.134 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.340042e-03 | 2.134 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.340042e-03 | 2.134 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 9.286010e-03 | 2.032 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.233437e-03 | 2.084 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.143598e-03 | 2.146 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 9.094131e-03 | 2.041 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.143598e-03 | 2.146 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.484193e-03 | 2.071 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.286010e-03 | 2.032 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 8.484193e-03 | 2.071 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.025288e-03 | 2.153 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.349558e-03 | 2.134 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.570199e-03 | 2.019 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.713012e-03 | 2.013 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.041139e-02 | 1.982 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.087840e-02 | 1.963 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.137208e-02 | 1.944 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.150539e-02 | 1.939 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.150539e-02 | 1.939 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.157932e-02 | 1.936 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.204855e-02 | 1.919 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.264898e-02 | 1.898 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.264898e-02 | 1.898 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.264898e-02 | 1.898 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.264898e-02 | 1.898 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.284539e-02 | 1.891 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.337635e-02 | 1.874 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.434032e-02 | 1.843 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.434032e-02 | 1.843 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.434032e-02 | 1.843 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.439978e-02 | 1.842 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.629674e-02 | 1.788 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.629674e-02 | 1.788 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.629674e-02 | 1.788 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.629674e-02 | 1.788 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 1.739446e-02 | 1.760 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.823983e-02 | 1.739 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.834329e-02 | 1.737 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.957527e-02 | 1.708 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.957527e-02 | 1.708 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.993755e-02 | 1.700 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.054247e-02 | 1.687 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.123963e-02 | 1.673 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.277650e-02 | 1.643 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.289696e-02 | 1.640 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.289696e-02 | 1.640 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.310782e-02 | 1.636 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.394475e-02 | 1.621 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 2.415210e-02 | 1.617 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.507908e-02 | 1.601 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.540903e-02 | 1.595 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.540903e-02 | 1.595 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.603657e-02 | 1.584 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 2.686211e-02 | 1.571 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.690449e-02 | 1.570 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.715507e-02 | 1.566 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.715507e-02 | 1.566 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.786629e-02 | 1.555 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.786629e-02 | 1.555 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.787293e-02 | 1.555 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.808060e-02 | 1.552 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.847377e-02 | 1.546 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.933732e-02 | 1.533 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.933732e-02 | 1.533 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.963079e-02 | 1.528 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 3.061718e-02 | 1.514 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.068281e-02 | 1.513 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.079631e-02 | 1.512 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.079631e-02 | 1.512 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.079631e-02 | 1.512 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.091322e-02 | 1.510 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 3.091322e-02 | 1.510 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 3.162720e-02 | 1.500 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.260096e-02 | 1.487 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.323386e-02 | 1.478 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.323386e-02 | 1.478 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.402592e-02 | 1.468 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.501589e-02 | 1.456 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.501589e-02 | 1.456 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.724919e-02 | 1.429 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 3.793827e-02 | 1.421 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.960429e-02 | 1.304 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 4.960429e-02 | 1.304 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 4.960429e-02 | 1.304 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 3.951777e-02 | 1.403 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.429800e-02 | 1.354 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.429800e-02 | 1.354 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.429800e-02 | 1.354 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.935186e-02 | 1.307 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.038735e-02 | 1.394 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.387247e-02 | 1.358 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.387247e-02 | 1.358 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.133278e-02 | 1.290 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.133278e-02 | 1.290 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.530673e-02 | 1.257 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.530673e-02 | 1.257 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.472838e-02 | 1.349 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.328482e-02 | 1.364 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 4.188509e-02 | 1.378 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.780875e-02 | 1.238 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.467391e-02 | 1.262 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 4.960429e-02 | 1.304 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.530673e-02 | 1.257 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 5.479550e-02 | 1.261 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.960429e-02 | 1.304 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 4.472838e-02 | 1.349 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.467391e-02 | 1.262 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.133278e-02 | 1.290 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 4.002787e-02 | 1.398 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.472838e-02 | 1.349 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.042813e-02 | 1.297 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.437852e-02 | 1.265 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.836208e-02 | 1.234 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 5.866919e-02 | 1.232 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 5.866919e-02 | 1.232 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 5.866919e-02 | 1.232 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.944188e-02 | 1.226 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.025809e-02 | 1.220 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.175084e-02 | 1.209 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.373692e-02 | 1.196 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.416097e-02 | 1.193 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.609781e-02 | 1.180 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.609781e-02 | 1.180 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.609781e-02 | 1.180 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.819024e-02 | 1.166 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 6.819024e-02 | 1.166 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.819024e-02 | 1.166 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 6.819024e-02 | 1.166 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 6.825334e-02 | 1.166 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.825334e-02 | 1.166 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.825334e-02 | 1.166 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.825334e-02 | 1.166 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.825334e-02 | 1.166 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 6.825334e-02 | 1.166 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 6.835055e-02 | 1.165 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 6.835055e-02 | 1.165 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 6.835055e-02 | 1.165 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 6.835055e-02 | 1.165 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 6.835055e-02 | 1.165 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 6.835055e-02 | 1.165 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.062883e-02 | 1.151 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.131512e-02 | 1.147 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.218597e-02 | 1.142 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.391060e-02 | 1.131 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.497461e-02 | 1.125 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 7.727803e-02 | 1.112 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.830977e-02 | 1.106 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.830977e-02 | 1.106 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.830977e-02 | 1.106 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.851507e-02 | 1.105 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 8.174527e-02 | 1.088 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 8.248031e-02 | 1.084 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 8.248031e-02 | 1.084 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.248031e-02 | 1.084 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.252805e-02 | 1.083 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 8.754607e-02 | 1.058 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.789096e-02 | 1.056 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 9.192381e-02 | 1.037 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 9.192381e-02 | 1.037 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 9.235311e-02 | 1.035 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.275870e-02 | 1.033 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.632406e-02 | 1.016 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.762380e-02 | 1.010 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.886787e-02 | 1.005 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.886787e-02 | 1.005 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 9.886787e-02 | 1.005 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 9.966476e-02 | 1.001 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 9.966476e-02 | 1.001 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 9.966476e-02 | 1.001 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 9.966476e-02 | 1.001 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 9.966476e-02 | 1.001 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.007564e-01 | 0.997 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.007564e-01 | 0.997 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.007564e-01 | 0.997 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.007564e-01 | 0.997 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.026960e-01 | 0.988 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.036129e-01 | 0.985 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.036129e-01 | 0.985 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.049868e-01 | 0.979 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.054382e-01 | 0.977 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.054382e-01 | 0.977 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.060793e-01 | 0.974 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.064808e-01 | 0.973 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.092481e-01 | 0.962 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.104051e-01 | 0.957 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.108821e-01 | 0.955 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.108821e-01 | 0.955 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.134897e-01 | 0.945 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.134897e-01 | 0.945 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 1.134897e-01 | 0.945 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.134897e-01 | 0.945 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 1.174202e-01 | 0.930 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.174202e-01 | 0.930 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 1.320369e-01 | 0.879 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 1.320369e-01 | 0.879 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.320369e-01 | 0.879 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 1.913769e-01 | 0.718 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.913769e-01 | 0.718 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.913769e-01 | 0.718 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.913769e-01 | 0.718 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.195103e-01 | 0.659 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.195103e-01 | 0.659 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.195103e-01 | 0.659 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.195103e-01 | 0.659 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.195103e-01 | 0.659 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 2.195103e-01 | 0.659 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.709423e-01 | 0.767 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.709423e-01 | 0.767 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.210902e-01 | 0.917 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.210902e-01 | 0.917 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 1.962492e-01 | 0.707 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.090712e-01 | 0.680 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.219748e-01 | 0.654 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.349390e-01 | 0.629 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.655709e-01 | 0.781 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.723806e-01 | 0.764 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.238332e-01 | 0.650 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.198357e-01 | 0.921 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.198357e-01 | 0.921 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.330882e-01 | 0.632 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.330882e-01 | 0.632 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.330882e-01 | 0.632 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.862818e-01 | 0.730 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.933647e-01 | 0.714 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.933647e-01 | 0.714 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.077739e-01 | 0.682 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.788542e-01 | 0.748 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.616267e-01 | 0.791 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.532118e-01 | 0.815 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.512985e-01 | 0.820 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.512985e-01 | 0.820 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.965531e-01 | 0.707 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 2.349390e-01 | 0.629 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.792857e-01 | 0.746 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.195103e-01 | 0.659 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.709423e-01 | 0.767 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.962492e-01 | 0.707 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.238332e-01 | 0.650 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.862818e-01 | 0.730 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.457554e-01 | 0.836 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.090712e-01 | 0.680 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.238332e-01 | 0.650 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 1.320369e-01 | 0.879 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.622312e-01 | 0.790 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 1.709423e-01 | 0.767 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.090712e-01 | 0.680 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.055574e-01 | 0.687 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.534808e-01 | 0.814 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.917725e-01 | 0.717 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.224090e-01 | 0.912 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.709423e-01 | 0.767 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.090712e-01 | 0.680 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.457554e-01 | 0.836 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.457554e-01 | 0.836 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 2.146535e-01 | 0.668 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 1.288717e-01 | 0.890 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 2.349390e-01 | 0.629 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.585072e-01 | 0.800 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.933647e-01 | 0.714 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.967606e-01 | 0.706 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.967606e-01 | 0.706 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.967606e-01 | 0.706 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 1.588607e-01 | 0.799 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.224791e-01 | 0.653 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.090712e-01 | 0.680 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.238332e-01 | 0.650 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.917725e-01 | 0.717 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 1.622312e-01 | 0.790 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.913769e-01 | 0.718 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.224090e-01 | 0.912 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.330882e-01 | 0.632 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.330882e-01 | 0.632 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.876491e-01 | 0.727 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 1.666415e-01 | 0.778 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.055574e-01 | 0.687 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.933647e-01 | 0.714 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 1.856195e-01 | 0.731 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 1.515876e-01 | 0.819 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 1.320369e-01 | 0.879 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.195103e-01 | 0.659 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.342104e-01 | 0.872 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.299320e-01 | 0.638 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.876491e-01 | 0.727 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.299798e-01 | 0.886 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.137126e-01 | 0.670 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 1.913769e-01 | 0.718 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.195103e-01 | 0.659 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.195103e-01 | 0.659 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.342104e-01 | 0.872 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 2.219748e-01 | 0.654 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.039841e-01 | 0.690 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.005302e-01 | 0.698 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.467461e-01 | 0.833 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.391285e-01 | 0.857 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.356650e-01 | 0.868 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 2.219748e-01 | 0.654 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 2.238332e-01 | 0.650 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.209183e-01 | 0.918 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 2.299320e-01 | 0.638 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.180116e-01 | 0.662 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.925470e-01 | 0.715 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.349390e-01 | 0.629 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.498262e-01 | 0.824 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 1.655709e-01 | 0.781 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 1.701771e-01 | 0.769 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.835316e-01 | 0.736 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.224090e-01 | 0.912 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.979042e-01 | 0.704 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 1.709423e-01 | 0.767 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.241873e-01 | 0.906 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.518590e-01 | 0.819 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 1.979042e-01 | 0.704 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 2.368449e-01 | 0.626 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 2.374462e-01 | 0.624 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.424104e-01 | 0.615 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.424104e-01 | 0.615 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 2.424104e-01 | 0.615 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 2.424104e-01 | 0.615 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.450173e-01 | 0.611 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 2.466666e-01 | 0.608 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.466666e-01 | 0.608 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 2.466666e-01 | 0.608 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 2.466666e-01 | 0.608 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.466666e-01 | 0.608 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.466666e-01 | 0.608 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 2.466666e-01 | 0.608 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.466666e-01 | 0.608 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 2.466666e-01 | 0.608 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.479440e-01 | 0.606 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 2.485664e-01 | 0.605 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 2.489076e-01 | 0.604 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 2.615378e-01 | 0.582 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 2.626310e-01 | 0.581 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 2.659751e-01 | 0.575 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 2.659751e-01 | 0.575 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 2.683941e-01 | 0.571 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 2.707031e-01 | 0.568 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.728796e-01 | 0.564 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.728796e-01 | 0.564 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.728796e-01 | 0.564 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.728796e-01 | 0.564 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.728796e-01 | 0.564 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 2.728796e-01 | 0.564 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.728796e-01 | 0.564 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.728796e-01 | 0.564 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.728796e-01 | 0.564 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.728796e-01 | 0.564 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.728796e-01 | 0.564 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 2.728796e-01 | 0.564 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.728796e-01 | 0.564 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.740037e-01 | 0.562 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.740037e-01 | 0.562 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.740037e-01 | 0.562 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.802177e-01 | 0.553 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.802177e-01 | 0.553 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.870250e-01 | 0.542 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 2.870250e-01 | 0.542 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.870250e-01 | 0.542 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.897623e-01 | 0.538 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.897623e-01 | 0.538 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.926967e-01 | 0.534 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.981821e-01 | 0.526 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.981821e-01 | 0.526 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.981821e-01 | 0.526 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.981821e-01 | 0.526 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.981821e-01 | 0.526 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 2.981821e-01 | 0.526 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.981821e-01 | 0.526 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 2.981821e-01 | 0.526 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.992640e-01 | 0.524 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.992640e-01 | 0.524 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.992640e-01 | 0.524 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.992640e-01 | 0.524 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 2.993299e-01 | 0.524 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 2.993299e-01 | 0.524 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 2.993299e-01 | 0.524 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.000203e-01 | 0.523 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 3.000203e-01 | 0.523 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.000203e-01 | 0.523 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.000203e-01 | 0.523 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.089139e-01 | 0.510 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.089733e-01 | 0.510 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 3.129757e-01 | 0.504 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 3.129757e-01 | 0.504 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.129757e-01 | 0.504 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.150446e-01 | 0.502 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.150446e-01 | 0.502 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.158266e-01 | 0.501 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.185078e-01 | 0.497 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.203800e-01 | 0.494 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 3.226055e-01 | 0.491 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 3.226055e-01 | 0.491 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.226055e-01 | 0.491 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.226055e-01 | 0.491 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 3.226055e-01 | 0.491 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.226055e-01 | 0.491 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 3.226055e-01 | 0.491 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.226055e-01 | 0.491 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.226055e-01 | 0.491 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 3.226055e-01 | 0.491 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 3.226055e-01 | 0.491 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.229625e-01 | 0.491 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.229625e-01 | 0.491 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.258782e-01 | 0.487 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.258782e-01 | 0.487 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.265364e-01 | 0.486 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.281053e-01 | 0.484 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.332683e-01 | 0.477 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.364910e-01 | 0.473 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.387159e-01 | 0.470 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.387159e-01 | 0.470 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.387159e-01 | 0.470 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.387159e-01 | 0.470 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.387159e-01 | 0.470 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.388355e-01 | 0.470 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.395592e-01 | 0.469 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 3.434060e-01 | 0.464 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 3.434060e-01 | 0.464 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 3.434060e-01 | 0.464 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 3.434060e-01 | 0.464 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.461805e-01 | 0.461 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 3.461805e-01 | 0.461 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.461805e-01 | 0.461 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.461805e-01 | 0.461 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 3.461805e-01 | 0.461 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.461805e-01 | 0.461 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.461805e-01 | 0.461 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.461805e-01 | 0.461 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.461805e-01 | 0.461 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.461805e-01 | 0.461 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.472875e-01 | 0.459 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 3.472875e-01 | 0.459 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.514777e-01 | 0.454 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.514777e-01 | 0.454 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.568607e-01 | 0.448 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.568607e-01 | 0.448 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.568607e-01 | 0.448 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.568607e-01 | 0.448 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.568607e-01 | 0.448 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.641533e-01 | 0.439 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.641533e-01 | 0.439 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.641987e-01 | 0.439 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.664147e-01 | 0.436 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.664147e-01 | 0.436 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 3.664147e-01 | 0.436 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.689363e-01 | 0.433 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.689363e-01 | 0.433 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.689363e-01 | 0.433 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.689363e-01 | 0.433 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.689363e-01 | 0.433 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.689363e-01 | 0.433 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.689363e-01 | 0.433 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.689363e-01 | 0.433 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.689363e-01 | 0.433 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.689363e-01 | 0.433 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.689363e-01 | 0.433 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.736715e-01 | 0.428 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.767333e-01 | 0.424 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.767333e-01 | 0.424 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.767333e-01 | 0.424 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 3.767333e-01 | 0.424 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.767333e-01 | 0.424 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 3.767333e-01 | 0.424 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 3.791757e-01 | 0.421 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 3.791757e-01 | 0.421 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.850931e-01 | 0.414 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 3.854446e-01 | 0.414 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 3.865030e-01 | 0.413 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.892091e-01 | 0.410 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 3.892091e-01 | 0.410 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.892091e-01 | 0.410 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.892091e-01 | 0.410 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.909016e-01 | 0.408 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.909016e-01 | 0.408 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 3.909016e-01 | 0.408 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.909016e-01 | 0.408 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.909016e-01 | 0.408 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 3.909016e-01 | 0.408 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 3.909016e-01 | 0.408 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.949107e-01 | 0.404 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.949107e-01 | 0.404 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.988777e-01 | 0.399 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.015726e-01 | 0.396 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 4.015726e-01 | 0.396 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.015726e-01 | 0.396 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.015726e-01 | 0.396 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.121035e-01 | 0.385 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 4.121035e-01 | 0.385 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.121035e-01 | 0.385 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 4.121035e-01 | 0.385 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.121035e-01 | 0.385 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.127080e-01 | 0.384 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.138166e-01 | 0.383 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 4.138166e-01 | 0.383 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.180657e-01 | 0.379 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.196062e-01 | 0.377 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.196062e-01 | 0.377 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.230593e-01 | 0.374 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 4.230593e-01 | 0.374 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.259025e-01 | 0.371 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 4.259025e-01 | 0.371 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.259344e-01 | 0.371 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.259344e-01 | 0.371 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.259344e-01 | 0.371 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.259344e-01 | 0.371 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 4.259344e-01 | 0.371 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.259344e-01 | 0.371 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.264905e-01 | 0.370 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.325687e-01 | 0.364 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.325687e-01 | 0.364 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.325687e-01 | 0.364 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 4.325687e-01 | 0.364 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.325687e-01 | 0.364 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.325687e-01 | 0.364 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.325687e-01 | 0.364 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.325687e-01 | 0.364 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.325687e-01 | 0.364 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.325687e-01 | 0.364 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.325687e-01 | 0.364 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 4.325687e-01 | 0.364 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.325687e-01 | 0.364 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 4.325687e-01 | 0.364 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.325687e-01 | 0.364 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.337125e-01 | 0.363 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.379201e-01 | 0.359 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.379201e-01 | 0.359 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.379201e-01 | 0.359 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 4.379201e-01 | 0.359 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.388192e-01 | 0.358 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.414799e-01 | 0.355 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.415756e-01 | 0.355 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.497680e-01 | 0.347 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.497680e-01 | 0.347 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.497680e-01 | 0.347 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.497680e-01 | 0.347 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.497680e-01 | 0.347 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.497680e-01 | 0.347 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.507476e-01 | 0.346 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.523227e-01 | 0.345 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.523227e-01 | 0.345 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.523227e-01 | 0.345 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.523227e-01 | 0.345 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 4.523227e-01 | 0.345 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.523227e-01 | 0.345 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.523227e-01 | 0.345 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 4.523227e-01 | 0.345 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.538517e-01 | 0.343 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.614734e-01 | 0.336 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.614734e-01 | 0.336 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.614734e-01 | 0.336 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.674021e-01 | 0.330 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.713902e-01 | 0.327 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.713902e-01 | 0.327 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.713902e-01 | 0.327 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.713902e-01 | 0.327 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.713902e-01 | 0.327 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.713902e-01 | 0.327 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 4.713902e-01 | 0.327 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.713902e-01 | 0.327 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.713902e-01 | 0.327 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.722726e-01 | 0.326 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.730317e-01 | 0.325 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.730317e-01 | 0.325 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.730317e-01 | 0.325 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.741390e-01 | 0.324 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.752745e-01 | 0.323 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 4.844391e-01 | 0.315 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 4.844391e-01 | 0.315 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.844391e-01 | 0.315 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.897949e-01 | 0.310 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.897949e-01 | 0.310 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 4.897949e-01 | 0.310 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.897949e-01 | 0.310 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.897949e-01 | 0.310 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 4.897949e-01 | 0.310 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.897949e-01 | 0.310 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.897949e-01 | 0.310 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 4.897949e-01 | 0.310 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 4.897949e-01 | 0.310 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 4.897949e-01 | 0.310 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.897949e-01 | 0.310 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.897949e-01 | 0.310 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.897949e-01 | 0.310 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.897949e-01 | 0.310 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.956920e-01 | 0.305 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.956920e-01 | 0.305 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.956920e-01 | 0.305 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 5.023995e-01 | 0.299 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.043683e-01 | 0.297 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.043683e-01 | 0.297 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.067874e-01 | 0.295 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.067874e-01 | 0.295 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.067874e-01 | 0.295 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.073784e-01 | 0.295 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.073784e-01 | 0.295 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 5.075600e-01 | 0.295 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 5.075600e-01 | 0.295 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.075600e-01 | 0.295 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 5.075600e-01 | 0.295 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.075600e-01 | 0.295 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.075600e-01 | 0.295 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 5.075600e-01 | 0.295 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.075600e-01 | 0.295 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.075600e-01 | 0.295 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 5.075600e-01 | 0.295 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.177226e-01 | 0.286 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.177226e-01 | 0.286 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.177226e-01 | 0.286 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.177226e-01 | 0.286 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 5.177226e-01 | 0.286 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 5.177226e-01 | 0.286 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 5.177226e-01 | 0.286 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.216378e-01 | 0.283 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 5.247075e-01 | 0.280 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.247075e-01 | 0.280 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 5.247075e-01 | 0.280 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 5.247075e-01 | 0.280 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.247075e-01 | 0.280 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 5.247075e-01 | 0.280 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 5.247075e-01 | 0.280 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.247075e-01 | 0.280 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 5.269155e-01 | 0.278 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 5.269155e-01 | 0.278 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 5.284953e-01 | 0.277 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 5.284953e-01 | 0.277 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.284953e-01 | 0.277 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 5.284953e-01 | 0.277 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.333524e-01 | 0.273 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.349343e-01 | 0.272 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.389548e-01 | 0.268 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.391036e-01 | 0.268 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.391036e-01 | 0.268 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.391036e-01 | 0.268 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.397495e-01 | 0.268 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.407476e-01 | 0.267 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.412589e-01 | 0.267 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.412589e-01 | 0.267 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.412589e-01 | 0.267 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.412589e-01 | 0.267 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.412589e-01 | 0.267 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.412589e-01 | 0.267 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.412589e-01 | 0.267 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 5.465293e-01 | 0.262 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 5.495458e-01 | 0.260 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.531923e-01 | 0.257 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.551627e-01 | 0.256 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.572349e-01 | 0.254 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 5.572349e-01 | 0.254 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.572349e-01 | 0.254 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.572349e-01 | 0.254 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 5.572349e-01 | 0.254 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.572349e-01 | 0.254 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 5.572349e-01 | 0.254 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 5.572349e-01 | 0.254 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 5.572349e-01 | 0.254 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.572349e-01 | 0.254 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.572349e-01 | 0.254 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 5.582164e-01 | 0.253 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.598208e-01 | 0.252 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.598208e-01 | 0.252 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.598208e-01 | 0.252 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.598208e-01 | 0.252 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.598208e-01 | 0.252 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.598208e-01 | 0.252 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.598208e-01 | 0.252 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.602231e-01 | 0.252 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.693230e-01 | 0.245 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.699273e-01 | 0.244 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.699273e-01 | 0.244 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.726555e-01 | 0.242 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 5.726555e-01 | 0.242 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 5.726555e-01 | 0.242 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 5.726555e-01 | 0.242 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.726555e-01 | 0.242 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.726555e-01 | 0.242 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.726555e-01 | 0.242 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.833291e-01 | 0.234 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.872461e-01 | 0.231 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.872461e-01 | 0.231 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 5.875399e-01 | 0.231 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 5.875399e-01 | 0.231 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 5.875399e-01 | 0.231 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.875399e-01 | 0.231 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.875399e-01 | 0.231 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 5.875399e-01 | 0.231 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.875399e-01 | 0.231 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.877327e-01 | 0.231 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 5.896327e-01 | 0.229 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.896327e-01 | 0.229 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.019068e-01 | 0.220 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 6.019068e-01 | 0.220 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.019068e-01 | 0.220 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.019068e-01 | 0.220 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.019068e-01 | 0.220 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.019068e-01 | 0.220 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 6.019068e-01 | 0.220 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.019068e-01 | 0.220 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.027217e-01 | 0.220 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.027217e-01 | 0.220 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 6.086591e-01 | 0.216 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 6.086591e-01 | 0.216 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.139837e-01 | 0.212 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.157741e-01 | 0.211 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.157741e-01 | 0.211 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.157741e-01 | 0.211 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 6.157741e-01 | 0.211 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 6.157741e-01 | 0.211 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 6.157741e-01 | 0.211 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 6.157741e-01 | 0.211 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.157741e-01 | 0.211 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.157741e-01 | 0.211 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 6.179177e-01 | 0.209 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.291592e-01 | 0.201 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.291592e-01 | 0.201 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.291592e-01 | 0.201 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.291592e-01 | 0.201 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.291592e-01 | 0.201 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 6.291592e-01 | 0.201 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.291592e-01 | 0.201 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.291592e-01 | 0.201 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 6.302836e-01 | 0.200 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.325054e-01 | 0.199 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.359277e-01 | 0.197 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.396136e-01 | 0.194 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.420787e-01 | 0.192 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.420787e-01 | 0.192 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 6.420787e-01 | 0.192 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 6.420787e-01 | 0.192 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.420787e-01 | 0.192 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 6.420787e-01 | 0.192 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.538048e-01 | 0.185 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 6.545490e-01 | 0.184 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 6.545490e-01 | 0.184 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 6.545490e-01 | 0.184 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.545490e-01 | 0.184 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.545490e-01 | 0.184 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.545490e-01 | 0.184 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 6.545490e-01 | 0.184 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.545490e-01 | 0.184 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 6.545490e-01 | 0.184 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.593579e-01 | 0.181 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.607052e-01 | 0.180 | 1 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.616852e-01 | 0.179 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.616852e-01 | 0.179 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 6.665854e-01 | 0.176 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 6.665854e-01 | 0.176 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 6.665854e-01 | 0.176 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.665854e-01 | 0.176 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.665854e-01 | 0.176 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 6.665854e-01 | 0.176 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.665854e-01 | 0.176 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.697939e-01 | 0.174 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 6.782033e-01 | 0.169 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.782033e-01 | 0.169 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.782033e-01 | 0.169 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.782033e-01 | 0.169 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.782033e-01 | 0.169 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.782033e-01 | 0.169 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.813685e-01 | 0.167 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 6.813685e-01 | 0.167 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 6.859588e-01 | 0.164 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.859588e-01 | 0.164 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.894169e-01 | 0.162 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.894169e-01 | 0.162 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 6.894169e-01 | 0.162 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 6.937264e-01 | 0.159 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 6.937264e-01 | 0.159 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.002405e-01 | 0.155 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.002405e-01 | 0.155 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 7.002405e-01 | 0.155 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.002405e-01 | 0.155 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.013347e-01 | 0.154 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 7.013347e-01 | 0.154 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 7.019800e-01 | 0.154 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 7.106875e-01 | 0.148 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.106875e-01 | 0.148 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.106875e-01 | 0.148 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.106875e-01 | 0.148 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 7.106875e-01 | 0.148 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 7.106875e-01 | 0.148 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 7.106875e-01 | 0.148 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.106875e-01 | 0.148 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.207711e-01 | 0.142 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 7.207711e-01 | 0.142 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 7.207711e-01 | 0.142 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.207711e-01 | 0.142 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.207711e-01 | 0.142 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.232211e-01 | 0.141 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.232211e-01 | 0.141 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 7.283788e-01 | 0.138 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.299054e-01 | 0.137 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.300450e-01 | 0.137 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.302098e-01 | 0.137 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.305037e-01 | 0.136 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.398978e-01 | 0.131 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.398978e-01 | 0.131 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.417700e-01 | 0.130 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.489649e-01 | 0.126 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.489649e-01 | 0.126 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 7.489649e-01 | 0.126 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.489649e-01 | 0.126 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.489649e-01 | 0.126 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.489649e-01 | 0.126 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 7.502821e-01 | 0.125 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 7.547195e-01 | 0.122 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.577165e-01 | 0.120 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 7.577165e-01 | 0.120 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.577165e-01 | 0.120 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.577165e-01 | 0.120 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.577165e-01 | 0.120 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.661635e-01 | 0.116 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.661635e-01 | 0.116 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 7.661635e-01 | 0.116 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 7.661635e-01 | 0.116 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.661635e-01 | 0.116 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.677945e-01 | 0.115 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.682198e-01 | 0.115 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 7.690569e-01 | 0.114 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.690569e-01 | 0.114 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 7.743165e-01 | 0.111 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.750367e-01 | 0.111 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.821857e-01 | 0.107 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.821857e-01 | 0.107 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 7.833123e-01 | 0.106 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.865914e-01 | 0.104 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 7.897810e-01 | 0.102 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.897810e-01 | 0.102 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 7.897810e-01 | 0.102 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 7.897810e-01 | 0.102 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 7.921707e-01 | 0.101 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.970700e-01 | 0.099 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.971119e-01 | 0.098 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.041876e-01 | 0.095 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.041876e-01 | 0.095 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.060421e-01 | 0.094 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.110169e-01 | 0.091 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.110169e-01 | 0.091 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.110169e-01 | 0.091 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 8.110169e-01 | 0.091 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.110169e-01 | 0.091 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.110169e-01 | 0.091 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.132194e-01 | 0.090 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 8.176085e-01 | 0.087 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.176085e-01 | 0.087 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.239705e-01 | 0.084 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.239705e-01 | 0.084 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.239705e-01 | 0.084 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.301110e-01 | 0.081 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.301110e-01 | 0.081 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.319492e-01 | 0.080 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.323442e-01 | 0.080 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.360376e-01 | 0.078 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 8.360376e-01 | 0.078 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.360376e-01 | 0.078 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.417579e-01 | 0.075 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.417579e-01 | 0.075 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.472789e-01 | 0.072 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 8.472789e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.472789e-01 | 0.072 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.496042e-01 | 0.071 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.517654e-01 | 0.070 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.526076e-01 | 0.069 | 1 | 1 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.577508e-01 | 0.067 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.577508e-01 | 0.067 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.592877e-01 | 0.066 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 8.627147e-01 | 0.064 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.653795e-01 | 0.063 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 8.653795e-01 | 0.063 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.653795e-01 | 0.063 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 8.675057e-01 | 0.062 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 8.675057e-01 | 0.062 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.695672e-01 | 0.061 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.721298e-01 | 0.059 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.721298e-01 | 0.059 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 8.761487e-01 | 0.057 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.809003e-01 | 0.055 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.850577e-01 | 0.053 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.923456e-01 | 0.049 | 1 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.923476e-01 | 0.049 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.925552e-01 | 0.049 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.925552e-01 | 0.049 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.929429e-01 | 0.049 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 8.951567e-01 | 0.048 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.002880e-01 | 0.046 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.019647e-01 | 0.045 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.037697e-01 | 0.044 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.040915e-01 | 0.044 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.071301e-01 | 0.042 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.103732e-01 | 0.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 9.103732e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 9.103732e-01 | 0.041 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 9.103732e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 9.103732e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 9.103732e-01 | 0.041 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.135034e-01 | 0.039 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.135034e-01 | 0.039 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.135034e-01 | 0.039 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.165244e-01 | 0.038 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.181169e-01 | 0.037 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.194400e-01 | 0.036 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.194400e-01 | 0.036 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.212993e-01 | 0.036 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.222540e-01 | 0.035 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.222540e-01 | 0.035 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.222540e-01 | 0.035 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.249699e-01 | 0.034 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.275910e-01 | 0.033 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.284621e-01 | 0.032 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 9.301207e-01 | 0.031 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.301207e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.301207e-01 | 0.031 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.301207e-01 | 0.031 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.315019e-01 | 0.031 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.371927e-01 | 0.028 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.393876e-01 | 0.027 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.435502e-01 | 0.025 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.483926e-01 | 0.023 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 9.492651e-01 | 0.023 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.520514e-01 | 0.021 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.527504e-01 | 0.021 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.544024e-01 | 0.020 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.547836e-01 | 0.020 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.575353e-01 | 0.019 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 9.631712e-01 | 0.016 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.643464e-01 | 0.016 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.662021e-01 | 0.015 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.662021e-01 | 0.015 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.670846e-01 | 0.015 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.727044e-01 | 0.012 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.732706e-01 | 0.012 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.762156e-01 | 0.010 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.776322e-01 | 0.010 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.786678e-01 | 0.009 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.822381e-01 | 0.008 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.847643e-01 | 0.007 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.856739e-01 | 0.006 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.917915e-01 | 0.004 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.964169e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.967176e-01 | 0.001 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.967452e-01 | 0.001 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.980320e-01 | 0.001 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.986190e-01 | 0.001 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.986210e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.994760e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.995906e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.997208e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.998661e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999398e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999554e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999595e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999842e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999965e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 9.999998e-01 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |